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As cancer is pathologically and biologically complex, identifying a variety of 
information on its morphology, functionality, molecular composition, and biomechanics is 
desired for precise and personalized diagnosis and treatment. Medical ultrasound imaging 
is a relatively safe, cost-effective modality that provides a cross-sectional image of 
anatomy in real-time, but it suffers from low contrast and does not provide quantitative 
functional information on tissue for better detection and assessment of a suspicious lesion. 
To circumvent this limitation, researchers have introduced shear-wave elasticity imaging, 
which noninvasively measures Young’s modulus of tissue, spectroscopic photoacoustic 
imaging, which quantifies chromophores distribution in tissue, phase-change contrast 
agents, which are useful in imaging extravascular targets, and super-resolution imaging, 
which provides unprecedented spatial resolution beyond the diffraction limit for molecular 
imaging. This research engineers these methods to further improve their respective imaging 
capabilities. In addition, based on the improvements in each imaging method, this research 
introduces combined laser, ultrasound, and elasticity (CLUE) imaging that is uniquely 
capable of simultaneous and synergistic probing of acoustic, optical, and mechanical 






CHAPTER 1. INTRODUCTION 
1.1 Cancer and Medical Imaging 
Cancer is a major cause of death in the United States. In 2017, nearly one of every 
four Americans are expected to die of cancer, which is surpassed only by heart disease [1]. 
Early diagnosis and timely management of cancer is known to improve survival rates.  
Researchers have developed various medical imaging techniques, which have played an 
essential role in the detection, diagnosis, and treatment of cancer [2]. However, as cancer 
progresses, it undergoes complex pathological and biological changes. Thus, precise 
diagnosis and personalized treatment of cancer necessitates a variety of information on its 
morphology, functionality, molecular composition, and biomechanics [3-5]. It is desirable 
to gauge all of these various aspects of cancer to improve its detection, staging, treatment, 
and management [2, 6]. 
However, none of the currently used stand-alone biomedical imaging modalities 
provides this broad information on cancer, which has led to the development of hybrid or 
multi-modal approaches [2, 7, 8]. For example, a combination of positron emission 
tomography (PET) and computed tomography (CT) referred to as PET/CT synergistically 
complement each other, as PET offers metabolic contrast that can be superimposed on the 
superior anatomical visualization of CT. However, nuclear medicine-based imaging 
techniques are hamstrung by their reliance on the use of ionizing radioisotopes for contrast. 
Ultrasound (US) is a safe, noninvasive, real-time, portable, and cost-effective 
imaging modality. Thus, as a first-line screening tool, US imaging has been widely used in 
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the clinic to aid detection of cancers, such as breast, liver, thyroid, prostate cancer and 
others [9-13]. However, its sensitivity and specificity to cancerous tumors are relatively 
low compared to other imaging modalities, as the acoustic properties of a tumor and its 
surrounding tissue are similar [9]. Furthermore, US imaging is often operator dependent 
[14]. To address these limitations, various US-based imaging methods, including shear-
wave elasticity imaging (SWEI), spectroscopic photoacoustic (sPA) imaging, and contrast-
enhanced US imaging, have been rigorously investigated to provide mechanical, 
molecular, and functional images of cancer, supplementing the anatomical information 
given by traditional gray-scale B-scan images [15-19]. 
1.2 Ultrasound-based Imaging Techniques 
This sub-chapter introduces various ultrasound-based imaging techniques including 
SWEI, sPA imaging, and US imaging with contrast agents that could be respectively useful 
in characterizing a tumor in different perspectives. 
SWEI can quantify elastic properties of tissue noninvasively. As the pathological 
condition of cancer is closely related to its stiffness in many solid lesions, SWEI has shown 
great potential in differentiating benign and malignant tumors [20-22]. In principle, SWEI 
relies on shear waves generated by the application of acoustic radiation force (ARF). The 
propagation of the shear waves is then observed to estimate their velocity, as a shear-wave 
velocity (SWV) is associated with the shear modulus of tissue. Since SWEI was introduced 
by Sarvazyan et al. [23], many related methods have been developed to improve SWEI 
[24-28]. Furthermore, SWEI has been applied to several clinical applications, showing 
promising capabilities in cancer diagnosis and monitoring [20, 29, 30]. In addition, the 
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mechanical heterogeneity of cancer, which can be visualized by SWEI, is of interest, as it 
could indicate the malignancy of the tumor [31]. 
Photoacoustic (PA) imaging offers optical contrast from endogenous and/or 
exogenous absorbers in tissue based on the PA effect, creating acoustic signals in response 
to pulsed-laser irradiation and subsequent thermal expansion [32-34]. For example, 
hemoglobin in blood is a strong absorber providing adequate PA signals compared to other 
surrounding chromophores; Thus, hemoglobin contrast from PA has been used to identify 
the formation of vessels surrounding a tumor, as the structural complexity of tumor 
neovasculature is often an indicator of tumor malignancy [35]. Furthermore, the level of 
blood oxygen saturation (SO2), the ratio of oxygenated to total hemoglobin concentrations, 
is known to be highly associated with the pathological state of a tumor [36, 37]. Multi-
wavelength (i.e., spectroscopic) PA imaging, also referred to as sPA imaging, can estimate 
quantitative concentrations of multiple chromophores, and oxygenated and deoxygenated 
hemoglobin have unique optical absorption spectra. Thus, sPA imaging has been widely 
studied to measure the SO2 level in tumors. Malignant tumors and metastatic sentinel 
lymph nodes have been shown to have a lower level of SO2 compared to normal tissue [38-
43]. 
Microbubbles are a clinically-approved contrast agent widely used in the clinic, as 
they provide superior contrast over traditional gray-scale US images [44-47]. Pulse 
inversion-based methods are typically used to detect the nonlinear response of 
microbubbles to an applied acoustic field. Recently, to further expand the utility of 
microbubbles, sub-micrometer-sized phase-change contrast agents that can form 
microbubbles in situ in response to an acoustic or optical trigger (i.e., perfluorocarbon 
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nanodroplets) have been introduced [48-53]. Because of their relatively small size, they 
have the potential to extravasate from endothelial fenestrations in cancer neovasculature 
and are thus capable of imaging extravascular targets. Our group and others have focused 
on optically-triggered perfluorohexane nanodroplets (PFHnDs) that can repeatedly 
vaporize and recondense, providing repeatable high-contrast PA and US signals [52, 54-
56]. These agents have shown great potential in contrast-enhanced imaging and super-
resolution imaging for lymph node localization and brain vasculature mapping. High-
frame-rate US imaging is typically required to capture the temporal response of the 
PFHnDs because their vaporization and recondensation process is transient and stochastic 
[57]. 
1.3 Research Goals 
 Traditional ultrasound B-mode images can provide real-time morphological 
information of tissue with excellent spatial resolution at great depths noninvasively, which 
helps physicians to identify various tissue abnormalities [58]. However, because the 
contrast of ultrasound imaging is relatively low, accessing anatomical information of the 
tissue is not always enough to detect and characterize many complex diseases, such as 
cancer. 
 SWEI, sPA imaging, contrast-enhanced ultrasound imaging, and super-resolution 
ultrasound imaging are emerging ultrasound-based imaging techniques capable of 
quantifying mechanical, functional, and molecular signatures of tissue noninvasively. 
Thus, the overall goals of this research are 1) to further advance these emerging imaging 
methods to improve their respective imaging capabilities, and 2) to develop an imaging 
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platform and imaging sequence capable of combining all of these imaging methods that 
can be potentially used for comprehensive diagnosis of cancer.  
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CHAPTER 2. DUAL-PHASE TRANSMIT FOCUSING FOR 
MULTIANGLE COMPOUND SHEAR-WAVE ELASTICITY 
IMAGING 
 The chapter was reproduced and reprinted with permission from H. Yoon, S. R. 
Aglyamov, and S. Y. Emelianov, “Dual-phase transmit focusing for multiangle compound 
shear-wave elasticity imaging”, IEEE Transactions on Ultrasonics, Ferroelectronics, and 
Frequency Control, vol. 64, no. 10, pp. 1439-1449, July, 2017. © 2017 IEEE. The reference 
can be found in [28]. 
 Shear-wave elasticity imaging (SWEI) can assess the mechanical properties of 
tissue quantitatively and noninvasively. To obtain the superior quality of SWEI images, 
the effective generation of acoustic radiation force is essential. Consequently, various 
transmit beamforming and pulse-sequencing methods have been investigated. This chapter 
introduces a technique referred to as “multi-angle compound SWEI” (MAC-SWEI) using 
simultaneous multi-angular push beams created by dual-phase transmit focusing to further 
improve the efficiency of shear wave generation, and therefore, to increase the quality of 
SWEI. Dual-phase transmit focusing creates both main and grating lobes (i.e., multi-
angular push beams for pushing) to adequately generate shear waves with multiple wave-
front angles by applying two phases alternately on array elements. Then, the generated 
multi-angular shear waves propagating are separated by multi-directional filtering, 
enabling the reconstruction of corresponding multiple shear-wave velocity (SWV) maps. 
To form a single image with a full field-of-view (FOV), these maps are combined, while 
pushing regions are omitted. Overall, we developed and tested the MAC-SWEI method 
using Field II beam simulations and phantom experiments with a programmable ultrasound 
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imaging system. Our results suggest that MAC-SWEI with dual-phase transmit focusing 
may improve the quality and the reliability of elasticity maps.  
2.1 Introduction 
 Reducing the number of push beam excitations while maintaining the image quality 
would be one of the remaining challenges in SWEI. For example, to reconstruct an SWV 
map with an entire FOV, multiple push beams should be applied subsequently at different 
lateral locations because the propagation of shear waves inside the push regions cannot be 
observed [21]. Moreover, the push beams applied on the stiff inclusion may result in 
overestimated SWVs [59]. However, the frame rate of SWV images is limited with this 
multiple push beam-based approach, which may cause motion artifacts resulted from 
physiological motion such as carotid artery pulsation, respiration, and cardiac activity [60]. 
In addition, the repeated generation of long push beams may raise safety concerns for 
patients, shorten the ultrasound transducer life time, and require a longer cooling time of 
the transducer [61, 62]. Therefore, fewer push events are desired. 
 This chapter aims to address these tradeoffs by introducing simultaneous multi-
angular push beams. Specifically, in a single pushing and tracking event, by creating the 
shear waves of various wave-front angles, which can be separated by multi-directional 
filtering [63-65], we simultaneously obtain multiple SWV maps corresponding to shear 
waves with different orientations and propagating in different directions. Thus, similar to 
CUSE methods [27, 66, 67], our method applies multiple push beams simultaneously and 
creates multiple SWV maps through multi-directional filtering. However, we use multi-
angular push beams instead of parallel push beams, to allow us to omit undesired regions, 
where the push beams are applied, before combining SWV maps. Furthermore, because of 
the angular compounding effect, we achieve the improved quality of SWV maps. 
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 To effectively create simultaneous multi-angular push beams, we introduce a new 
transmit beamforming technique called “dual-phase transmit focusing,” which 
alternatively applies two phases of ultrasound waves on every element of an array 
transducer. Dual-phase transmit focusing generates both main and grating lobes that can 
be as effective angular pushing beams. An overall imaging method that both uses 
simultaneous multi-angular push beams created by dual-phase transmit focusing and 
combines multiple SWV maps after eliminating undesirable SWV in the pushing regions, 
is referred to as “multi-angle compound SWEI” (MAC-SWEI). The developed MAC-
SWEI approach, not only improves the quality of elasticity images because of angular 
compounding, but also suppresses overestimated SWV in the pushing regions, because 
MAC-SWEI can remove these unreliable regions before combining SWV maps. 
2.2 Materials and Methods 
2.2.1 Dual-phase Transmit Focusing for Multi-angular Pushing 
 Grating lobes, caused by the discrete nature of array transducers, obstruct the 
identification of the exact positions of targets and have been regarded as unwanted artifacts 
in ultrasound imaging [68]. If the spatial sampling distance of the array elements is not 
short enough, grating lobes appear in the imaging plane periodically as a function of the 
incident angles θm as 
 
sin 𝜃𝑚 = 𝑚
𝜆
𝑑
 ,        𝑚 = ±1, ±2, …  (1) 
where λ is the wavelength of an ultrasound wave, d is the inter-element pitch (or spacing) 
of the transducer, and m represents the periodicity of the grating lobes [69, 70]. For 
example, if λ is 385 µm (i.e., if the sound speed of 1,540 m/s and the wave frequency of 4 
MHz are assumed), and d is 300 µm (i.e., typical spacing in clinical linear array 
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transducers), the grating lobes are formed outside of the imaging FOV. Therefore, the 
ultrasound array transducer, operating within its typical frequency range, is designed to 
avoid the grating lobes. However, if the element spacing is doubled similar to the sparse-
array techniques (i.e., if d becomes 600 µm) [70], then the incident angles of the first 
grating lobes (i.e., m = ±1) are about ±40° according to Equation 1, indicating that the 
sparse-array approach can create grating lobes within the FOV. However, the sparse-array 
approach suffers from significant loss in acoustic energy because it uses only half the 
number of elements when transmitting waves. More importantly, the relative magnitudes 
between grating lobes and a main lobe are not adjustable. 
 
Figure 1 – Generation of multi-angular push beams using the dual-phase transmit 
focusing approach. 
 To generate multi-angular push beams adequately and simultaneously, we 
introduce an effective way of creating both grating lobes and a main lobe, referred to as 
“dual-phase transmit focusing.” Unlike conventional focusing, which assigns the same 
phase on time-delayed transmit pulses to all array elements for coherent focusing, dual-
phase transmit focusing alternatively applies two phase-shifted (by ϕ0 and ϕ1) push pulses 
on the transducer, as depicted in Figure 1. In other words, in dual-phase transmit focusing, 
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transmitted pulses are focused at the same focal point as in conventional focusing; 
however, the pulses have two different alternating phases (i.e., the phase is the same on 
every other element and there is a constant phase difference between two adjacent 
elements). As a result of this repetitive phase difference between two adjacent elements, 
dual-phase transmit focusing produces the grating lobes at the same angles and positions 
as the sparse-array technique does. However, unlike the sparse-array technique, dual-phase 
transmit focusing can adjust the magnitude of grating lobes, because the grating lobes 
become a function of the dual-phase difference. Thus, dual-phase transmit focusing enables 
the adequate generation of both main and grating lobes with equivalent magnitudes. Note 
that the phase difference in dual-phase transmit focusing only determines the magnitudes 
of the grating and main lobes. The incident angles of grating lobes (θm) are determined by 
Equation 1 and the focus of the grating lobes is determined by the focus of the main lobe. 
Table 1 – Parameters used in the Field II simulation. 
 
Parameter Value 
Transducer (L7-4) Element pitch (mm) 0.298 
 Element width (mm) 0.250 
 Element height (mm) 7.0 
 Elevational focus (mm) 25 
 −6dB bandwidth (MHz) 3.5 to 6.5 
 Number of elements 128 
Excitation pulse Center frequency (MHz) 4.0 
 Sampling frequency (MHz) 100 
 Pulse duration (µs) 10 
 Pushing Focus (mm) 20 
 f-number 1.4 
 Apodization  Hanning window 
Medium Attenuation coefficient (dB/cm/MHz) 0.5 
 Speed of sound (m/s) 1,540 
 Parameter Value 
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 According to the phase difference, defined as Δϕ = |ϕ0−ϕ1| and ranging from 0° to 
180°, a variety of pushing configurations can be realized. For example, for Δϕ = 0°, because 
of the same phase applied to the push pulses, this configuration produces only the main 
lobe, as in the conventional pushing strategy. By contrast, if Δϕ = 180°, there is barely any 
amplitude of the main lobe at the focus because of the cancellation of two waves with 
opposite phases. Instead, we obtain two strong grating lobes. Overall, as Δϕ increases from 
0° to 180°, the magnitude of the main lobe decreases; however, the magnitudes of the two 
grating lobes increase, indicating that the magnitudes of the grating lobes and the main lobe 
can be adjusted based on the value of Δϕ. To assess dual-phase transmit focusing, we 
simulated acoustic fields using a Field II program [71, 72]. A transducer modeled for the 
simulation was the same as the linear array transducer used in experiments (L7-4, Philips 
Healthcare, Andover, MA, USA). All relevant simulation parameters are listed in Table 1. 
To evaluate the pushing ability of dual-phase transmit focusing, we obtained 181 fields 
with varying Δϕ from 0° to 180° with 1° increment. 
2.2.2 Multi-Angle Compound Shear Wave Elasticity Imaging 
 Through dual-phase transmit focusing, which effectively produces simultaneous 
multi-angular push beams, we implemented multi-angle compound SWEI (MAC-SWEI). 
Like other SWEI-based methods, MAC-SWEI also consists of three steps, shown in Figure 
2: (1) pushing the tissue to generate shear waves, (2) tracking the propagation of shear 
waves, and (3) reconstructing and compounding SWV maps. The main difference between 
MAC-SWEI and other SWEI-based techniques is that MAC-SWEI employs grating and 
main lobes created simultaneously by dual-phase transmit focusing as pushing sources, 
generating the shear waves with various wave-front angles. Multi-directional filtering was 
used to separate these angular shear waves, leading to the reconstruction of corresponding 
individual SWV maps. Since we know the exact location of push regions and the fact that 
the SWV values in push regions have the potential to be unreliable, our method excludes 
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all SWV values in each push region before combining them. Thus, this approach can result 
in a reliable SWV map, spanning a full FOV in a single pushing and tracking event. 
 A programmable ultrasound research machine (Vantage 256TM, Verasonics Inc., 
Redmond, WA, USA), equipped with the L7-4 linear array transducer (see Table 1) was 
used in this study. The ultrasound system was used to generate push pulses and to record 
post-beamformed IQ data. The acquired data were processed offline using MATLAB (The 
MathWorks Inc., Natick, MA, USA). To create the multi-angular push beams (one main 
and two left/right grating lobes), we applied Δϕ of 140° for dual-phase transmit focusing. 
Additionally, we used Δϕ’s of 0° and 180° to analyze how the choice of Δϕ affects the 
generation of shear waves. 
 
Figure 2 – Overall procedures of multi-angle compound SWEI (MAC-SWEI). 
 To realize the phase shift Δϕ, we delayed the signals on every other element. The 










where f0 is the center frequency of a push pulse. For example, for f0 = 4 MHz and Δϕ = 
140°, the required time delay τΔϕ was about 97.2 ns. Due to a master clock of 250 MHz in 
the Verasonics system, τΔϕ applied in the system was 96 ns (i.e., the closest multiple of 4 
ns time resolution), indicating that Δϕ’s of 138.24° and 178.56° were used in the system 
on behalf of ideal Δϕ’s of 140° and 180°, respectively. 
 In experiments, the duration of the excitation pulse was 600 µs while in the Field 
II simulation, we used a pulse duration of 10 µs to decrease the computational time. All 
other parameters were the same as listed in Table 1. After applying the push pulse, the 
generated shear waves were recorded using ultrafast plane wave imaging [73]. The three 
angles of the plane waves, whose center frequency was 4.3 MHz, were −4°, 0°, and 4°. 
Their pulse-repetition frequency (PRF) was 10 kHz, and thus, the effective PRF was 3.33 
kHz. 
 To visualize the propagation of shear waves, we estimated axial particle velocities 
from acquired IQ sequences using a two-dimensional auto-correlation approach [74, 75]. 
The number of ensembles was three, and the length of the auto-correlation kernel was 2λ. 
Then, we applied multi-directional filtering [64, 65, 76], originally introduced in magnetic 
resonance elastography [63], to multi-angular shear waves to separate them in space and 
time. To design the multi-directional filter, we calculated the angles of two grating lobes, 
±40°, from Equation 1. Although our dual-phase configuration generated six shear waves 
from three push beams (i.e., one main and two left/right grating lobes), we eliminated two 
shear waves that were traveling toward the upper right and upper left corners of FOV 
because of their small propagation distances. Thus, MAC-SWEI utilized four shear waves: 
right-to-left from the left grating lobe (RLGL), right-to-left from the main lobe (RLML) left-
 14 
to-right from the right grating lobe (LRGL), and left-to-right from the main lobe (LRML), 
depicted in Figure 2. 
 From the four shear-wave sequences (RLGL, RLML, LRGL, and LRML), four 
corresponding SWV maps were reconstructed using a two-dimensional cross-correlation 
approach [76, 77]. Here, the distance between the cross-correlating shear wave signals in 
both lateral and axial directions was 2.1 mm. Thereafter, the reconstructed SWV maps were 
filtered using a two-dimensional median filter (1.0 mm x 1.0 mm). Before combining these 
four SWV maps, because we know the positions and the angles of all pushing sources, the 
regions excited by push beams were excluded. Thus, we defined the binary maps R(x,y,n) 
(indicated by black dashed regions in four estimated SWV maps in Figure 2), which 
determined the SWV maps that will be combined. Here, x and y represent the lateral and 
axial positions and n denotes the order of the SWV maps used for compounding (n = 
1,2,3,4). R(x,y,n) = 1 or 0 represents an SWV value of the nth SWV map at x and y that is 
included or excluded, respectively, in the combined SWV map. To produce a combined 
single SWV map, a weighted summation of four SWV maps was used as 
 
SWVCMPND(𝑥, 𝑦) =
∑ SWV(𝑥, 𝑦, 𝑛) ∙ R(𝑥, 𝑦, 𝑛)4𝑛=1
∑ R(𝑥, 𝑦, 𝑛)4𝑛=1
, (3) 
where SWVCMPND(x,y) is the compounded SWV map, and x and y represent the lateral and 
axial positions. SWV(x,y,n) contains four SWV maps acquired from their corresponding 
angular shear waves.  Because the push regions can be eliminated, the combined MAC-
SWEI-based SWV maps are bias-reduced and reliable. Furthermore, by combining 
multiple SWV maps resulting from the shear waves, oriented differently and propagating 
in different directions, MAC-SWEI improves the quality of an SWV map similar to 
angular-spatial compounding used in the B-mode or strain elastography [78]. 
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 In addition to MAC-SWEI with the shear waves with four wave-front angles, 
created by applying Δϕ of 140°, we realized two more configurations with Δϕ’s of 0° and 
180° for comparison (Figure 3). First, Δϕ of 0° generated only the main lobe, resulting in 
two SWV maps from RLML and LRML. By contrast, Δϕ of 180° created only the two grating 
lobes, resulting in two SWV maps from RLGL and LRGL. With Δϕ = 140°, four SWV maps 
from all three lobes were generated. Thus, for Δϕ ≠ 0°, the two shear waves from the two 
grating lobes (RLGL and LRGL) propagate the push regions of each other (i.e., RLGL travels 
to the region where LRGL is created, and vice versa), allowing for the reconstruction of 
SWV maps with an entire FOV. 
 
Figure 3 – Three available pushing configurations by dual-phase transmit focusing 
and combining of corresponding SWV maps. 
2.2.3 Phantom Experiments and Assessment Metrics 
 To assess the performance of MAC-SWEI, we imaged a quality assurance elasticity 
phantom (Model 049, CIRS Inc., Norfolk, VA, USA) containing several spherical 
inclusions within a homogeneous background. The nominal SWV values of the stiffest 
inclusion and the background are 5.11 m/s and 2.86 m/s (80 kPa and 25 kPa in terms of 
Young’s modulus), respectively. To verify and compare various available configurations 
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of dual-phase transmit focusing, the stiffest inclusion and the homogeneous background 
were evaluated with three Δϕ’s—0°, 140°, and 180°—, which create one main lobe, three 
lobes, and two grating lobes, respectively. In addition, we placed the inclusion at two 
locations: the center of the image and +10 mm to the right from the center (i.e., the inclusion 
was positioned at the same depth, but it was displaced laterally). For quantitative 
evaluation, we calculated the mean and the standard deviation (STD) of the SWV values 
in a region-of-interest (ROI). For the homogeneous background, when Δϕ = 0°, the means 
and the STDs were estimated only in the non-pushing regions, but when Δϕ = 140° and 
180°, all of the SWV regions were used. Two circular ROIs at the same depth covering the 
inclusion and the background region were used. We also assessed a blind area (BA) to 
explore the amount of unacceptable outliers in the SWV map [79]. Here, we classified an 
SWV value larger than (mean+3·STD) or less than (mean−3·STD) as an unacceptable 
SWV value and then computed the BA by the number of unreliable pixels in the SWV 
map, divided by the number of all pixels. Furthermore, we evaluated a contrast-to-noise 












× 100, (5) 
where µI and µB, and σI and σB in Equation 4 indicate the means and the STDs of the SWV 
values in the inclusion and background regions, respectively.  For % error in Equation 5, 
cE and cN represent the estimated and nominal SWV values in the ROI, respectively. 
2.2.4 Safety Measurements 
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 To ensure the clinical applicability of the MAC-SWEI technique, we measured 
acoustic parameters, including the mechanical index (MI), the spatial peak temporal 
average intensity (ISPTA), and the spatial peak pulse average intensity (ISPPA). Currently, the 
Food and Drug Administration (FDA) limits the MI, the ISPTA, and the ISPPA to 1.9, 720 













where Pr,derated is the derated peak rarefactional pressure at the focus of the main and grating 
lobes (MPa), and fC is the center frequency (4.0 MHz). PIIderated is the derated pulse 
intensity integral (µJ/cm2), PRF is the pulse-repetition frequency of the pushing pulse (1 














where v(t) represents the measured voltage. The sensitivity of a hydrophone is denoted by 
Ml(fC), where fC is the center frequency of a pulsed wave. The beginning and end times of 
the pulse are denoted by t1 and t2, ρ is the density of water (1,000 kg/m
3), and c is the speed 
of sound in water (1,484 m/s). To reflect the attenuation of ultrasound in tissue, we derated 
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the recorded waveforms with an attenuation coefficient of 0.3 dB/cm/MHz. We used a 0.2-
mm needle hydrophone (Precision Acoustics Ltd., Dorchester, Dorset, UK) and a DC 
coupler (DCPS233, Precision Acoustics Ltd., Dorchester, Dorset, UK) to acquire acoustic 
pressures, recorded by an oscilloscope (PicoScope 3406D, Pico Technology Ltd., St Neots, 
Cambridgeshire, UK). 
2.3 Results and Discussion 
2.3.1 Multi-Angular Acoustic Radiation Force Fields 
 
Figure 4 – Simulated multi-angular acoustic pressure fields created by dual-phase 
transmit focusing with Δϕ’s of (a) 0°, (b) 60°, (c) 120°, and (d) 180°. 
 Field II simulation results of normalized acoustic pressure fields created by dual-
phase transmit focusing with four selected Δϕ’s (0°, 60°, 120°, and 180°) are shown in 
Figure 4. In total, 181 fields (from 0° to 180°) were simulated, and an average execution 
time for each field was 165.8 s on a desktop computer with Intel(R) Core(TM) i7-6700K 
at 4.0 GHz. For Δϕ = 0°, dual-phase transmit focusing created only the main lobe (Figure 
4 (a)). However, for Δϕ ≠ 0°, the periodic incoherency in the transmit phases introduced 
the grating lobes in the FOV. As Δϕ increased from 0° to 180°, the magnitudes of the 
grating lobes increased, while that of the main lobe decreased. Finally, because Δϕ of 180° 
canceled the main lobe at the focus, only the two strongest grating lobes are observed 
(Figure 4 (d)). 
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 Figure 5 shows the maximum acoustic pressure of the main and grating lobes as a 
function of Δϕ. Again, as Δϕ increased, the magnitude of the main lobe decreased whereas 
those of the grating lobes increased. The intersection of the main and grating lobe curves 
(a red circle in Figure 5) indicates that the value of phase difference (Δϕ is around 130°) 
could generate three push beams of equal magnitude. Therefore, the phase difference Δϕ 
determines the distribution of the acoustic energy between the main and grating lobes in 
dual-phase transmit focusing. These results suggest that the magnitude of the multi-angular 
push beams can be delicately controlled. 
 
Figure 5 – Normalized acoustic pressure of the main lobe and the grating lobes as a 
function of Δϕ. 
2.3.2 Shear Waves Created with Dual-Phase Transmit Focusing 
 The generation and the propagation of shear waves, created by dual-phase transmit 
focusing with three Δϕ’s (0°, 140°, and 180°) in the homogeneous background region of 
the phantom as a function of time, are shown in Figure 6. Here, we applied three Δϕ’s to 
demonstrate that dual-phase transmit focusing generates shear waves as expected. Indeed, 
Δϕ = 0° generated two shear waves from the main lobe, similar to conventional SWEI; Δϕ 
= 140° created one main and two grating lobes that induced the shear waves of three distinct 
angles. As the shear waves induced by the grating lobes traveled a greater distance than 
those induced by the main lobe in the FOV, we applied 140° (instead of 130°, as indicated 
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in Figure 5) of Δϕ, which resulted in the slightly stronger grating lobes compared with the 
main lobe. Finally, for Δϕ = 180°, only two grating lobes were produced, and thus, 
propagation of two tilted shear waves were observed from the third row images in Figure 
6. 
 
Figure 6 – Estimated axial velocity sequences in the homogeneous region of the 
phantom with multiple choices of Δϕ’s at various time points. Rows represent three 
Δϕ’s (0°, 140°, and 180°). Columns represent four time points (0.5 ms, 1.5 ms, 2.5 ms, 
and 3.5 ms) after pushing. 
2.3.3 Homogeneous Region 
 From three sets of shear-wave sequences (Figure 6) created by three pushing 
configurations (Δϕ’s of 0°, 140°, and 180°), we reconstructed the final combined SWV 
maps, as shown in Figure 7. To obtain the SWV maps in Figure 7, we first applied multi-
directional filtering that separates shear waves with several angles, leading to the 
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reconstruction of corresponding SWV maps. Thereafter, these SWV maps were combined, 
allowing us to obtain final SWV maps covering a full FOV, as shown in Figure 7. For Δϕ 
= 0°, none of the two shear waves (RLML and LRML) from a main lobe propagated through 
the pushing region, and a final SWV map had a limited FOV (Figure 7 (b)). By contrast, 
for Δϕ ≠ 0° (i.e., Δϕ = 140° and Δϕ = 180°), shear waves covered the pushing regions of 
each other, and a final SWV map had a full FOV (Figure 7 (c) and (d)). However, because 
multi-directional filtering cannot completely separate different angles of shear waves, 
slightly overestimated SWV values were observed in the regions where the two grating 
lobes were generated. To reduce these possible artifacts, multi-directional filter masks 
should be carefully designed according to the angle and the bandwidth of the shear waves. 
 
Figure 7 – Experimental results on the homogeneous region. (a) B-scan image and 
reconstructed SWV maps with Δϕ’s of (b) 0°, (c) 140°, and (d) 180°. 
Table 2 – Quantitative assessment results in the homogeneous background. 
 Δϕ = 0° Δϕ = 140° Δϕ = 180° 
Mean ± STD (m/s) 2.84 ± 0.15 2.85 ± 0.14 2.86 ± 0.16 
% error (%) −0.86 −0.28 0.07 
Blind area (BA) (%) 15.28 0.62 2.26 
 For the quantitative evaluation, we computed the mean, the STD, the % error, and 
the BA of the SWV maps in the homogeneous background regions (Table 2). Here, for Δϕ 
= 0°, the mean and the STD were estimated only in the non-pushing regions (as indicated 
by dotted black boxes in Figure 7 (b)), but for Δϕ = 140° and Δϕ = 180°, all of the SWV 
 22 
regions were used. However, for computing the BA, the entire region of the SWV maps 
was used. The differences among the means, the STDs, and the % errors obtained from the 
three Δϕ’s were not noticeable. The BA indicates that Δϕ of 140° yields the most reliable 
SWV map with the widest FOV coverage. For Δϕ of 0°, accurate reconstruction of the 
SWV map within the pushing region was not possible due to artifacts, resulting in the 
largest BA among the three pushing schemes. 
2.3.4 Single Hard Spherical Inclusion within Background 
 
Figure 8 – Experimental results from the region of the phantom containing a single 
stiff inclusion at two lateral positions (0 mm and + 10 mm).  (a) B-scan image where 
the inclusion is located at 0 mm and the corresponding SWV maps obtained with Δϕ’s 
of (b) 0°, (c) 140°, and (d) 180°.  (e) B-scan image where the inclusion is located at +10 
mm and the corresponding SWV maps obtained with Δϕ’s of (f) 0°, (g) 140°, and (h) 
180°. 
 Figure 8 shows the reconstructed SWV maps of a region with a single hard 
spherical inclusion at two positions (0 mm and +10 mm) using three Δϕ’s (0°, 140°, and 
180°). As a result, the measurement at Δϕ = 0° failed to reliably reconstruct the inclusion 
in the pushing region (Figure 8 (b)), but once the push beam was off the inclusion, the 
inclusion was appropriately reconstructed in the SWV map (Figure 8 (f)). However, 
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regardless of the inclusion location, both Δϕ’s of 140° and 180° consistently and reliably 
reconstructed the SWV maps for both lateral positions at 0 mm and +10 mm. The dotted 
black circles (10 mm diameter) in Figure 8 outline the position and the size of the inclusion. 
Overall, the shape and the size of the inclusion obtained, based on the SWV map values, 
show good agreement with the actual characteristics of the inclusion. However, the size of 
the inclusion in the SWV maps appears to be slightly smaller than the actual size of the 
inclusion. This is partially due to the kernel length of correlation used for estimating SWV 
values. 
Table 3 – Quantitative assessment results in the phantom with a stiff spherical target. 




Inclusion 6.36 ± 0.64 4.71 ± 0.19 4.69 ± 0.13 
Background 2.81 ± 0.12 2.87 ± 0.08 2.87 ± 0.04 
% error (%) 
Inclusion 24.39 −7.87 −8.19 
Background −1.91 0.33 0.46 




Inclusion 4.56 ± 0.15 4.73 ± 0.16 5.09 ± 0.28 
Background 2.79 ± 0.11 2.82 ± 0.05 2.85 ± 0.06 
% error (%) 
Inclusion −10.81 −7.35 −0.43 
Background −2.33 −1.23 −0.49 
CNR  N/A 11.22 7.85 
 Table 3 summarizes the quantitative assessment of the SWV maps presented in 
Figure 8 using the mean, the STD, the % error, and the CNR. First, for the inclusion located 
at the center (0 mm), the measurement with Δϕ of 0° suffered from overestimation of SWV 
within the inclusion region (% error is 24.39%) while Δϕ’s of 140° and 180° led to 
relatively stable reconstruction of SWV both within the inclusion region and the 
background. Furthermore, the CNR improvements of Δϕ’s of 140° and 180° over that of 
0° were 61.21% and 142.65%, respectively. For the inclusion displaced +10 mm laterally, 
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none of the methods suffered from an overestimation of SWV within the inclusion region. 
The overall % error results merely show slight underestimation of SWV in the inclusion, 
which may be due to a measurement error in the nominal value (±5%) or the spherical 
shape of the inclusion [81]. The CNR values of the three methods were similar, but Δϕ of 
140° yielded the highest CNR. Overall, at two positions of inclusion, the measurements 
with Δϕ of 140°, compared to the other measurements, showed the most consistent means 
and STDs. 
2.3.5 Safety Measurements 
Table 4 – Measured safety parameters with three Δϕ’s (0°, 140°, and 180°). 
Δϕ MI ISPTA (mW/cm2) ISPPA (W/cm2) 
0° 1.73 70.49 117.48 
140° 0.77 11.40 19.00 
180° 0.72 9.45 15.76 
FDA limit 1.9 720 190 
 The MI, the ISPTA, and the ISPPA, measured for three Δϕ’s (0°, 140°, and 180°) at the 
foci of the main and grating lobes (Table 4), indicate that the measured safety parameters 
were below the FDA regulatory limits. It is important to note that although we induced the 
same voltage (80 Vpp) and used the same number of active elements (i.e., the same f-
number) to generate ultrasound waves for the three pushing configurations, the distribution 
and the concentration of acoustic energy within FOV varied according to Δϕ. As illustrated 
in Figure 5, the acoustic pressure of the grating and main lobes is a function of Δϕ. For Δϕ 
= 0°, all acoustic energy is concentrated mostly in a main lobe, thus the acoustic outputs 
are the highest but within the FDA guideline. By contrast, pulses with Δϕ’s of 140° and 
180° divided the total acoustic energy into more than one push beam and, therefore, may 
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further reduce the safety concerns, thus providing another benefit of dual-phase transmit 
focusing. 
2.3.6 Two Potential Candidates for Creating Simultaneous Multi-Angular Push Beams 
 We can produce simultaneous multi-angular push beams in two more ways. One 
approach is to arrange and excite differently steered beams using the sub-divided apertures 
of an ultrasound transducer. This overall concept is similar to CUSE [76], but the 
introduced steering angles of the push beams are different, as shown in Figure 9 (a). 
However, a typical linear array transducer (e.g., L7-4, Philips Healthcare, Andover, MA, 
USA) has an element spacing of about 300 µm, which is similar to a wavelength of 4-5 
MHz ultrasound, unwanted grating lobes could appear in the FOV once the ultrasound 
beams are steered. These undesirable grating lobes cause the loss of acoustic energy and 
obscure the appropriate formation of acoustic radiation force fields. In addition, the sub-
divided, reduced size of sub-apertures broadens the width of each beam and degrades the 
pushing efficiency. Another way is to apply the sparse array technique that drives 
ultrasound waves using only every other element of an array, which deliberately brings two 
desirable grating lobes into the FOV for angular pushing, is illustrated in Figure 9 (b). 
However, as only half of the elements are used, half of the acoustic energy is lost 
accordingly. Furthermore, not only are we unable to control the magnitudes of the grating 
lobes, but their magnitudes are also much weaker than that of the main lobe [82]. Therefore, 
this approach may be ineffective in the creation of multi-angular push beams. 
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Figure 9 – Two possible ways of generating simultaneous multi-angular push beams: 
(a) steering with sub-divided apertures and (b) a sparse array technique. 
 Field II simulated acoustic pressure maps, produced with these two methods (i.e., 
steering with sub-apertures and the sparse array technique), are shown in Figure 10. For 
fair comparison, the same parameters, as listed in Table 1, were used for push pulses 
(except their arrangements on the transducer). First, for the steering angles of ±10°, no 
grating lobes appeared (Figure 10 (a)). However, as the steering angle increased from ±10° 
to ±40°, the grating lobes started to appear. As the steering angles became ±40°, which is 
desirable to separate the resultant multi-angular shear waves, the magnitudes of the 
unwanted grating lobes became similar to those of their main lobes (Figure 10 (c)). The 
sparse array technique simultaneously created desirable grating lobes and a main lobe 
(Figure 10 (d)). However, the magnitude of the grating lobes, compared to the main lobe, 
was considerably weaker and intractable. Dual-phase transmit focusing, which applies two 
phases on every other element (Figure 4), effectively overcame these limitations. 
According to the selected phase difference, dual-phase transmit focusing distributed the 
total acoustic energy to one main and two grating lobes, and unlike the sparse array 
technique, the approach did not suffer from energy loss. In addition, the dual-phase 
transmit approach uses an entire aperture (not sub-divided apertures) to create multi-
angular push beams, and thus, the width of the push beams, unlike those produced by sub-
apertures, does not widen. 
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Figure 10 – Simulated multiangular acoustic pressure fields created by the subdivided 
aperture approach with steering angles of (a) −10°, 0°, +10°, (b) −25°, 0°, +25°, (c) 
−40°, 0°, +40°, and (d) sparse-array technique. 
 Table 5 summarizes the results of the quantitative assessment of angular push 
beams based on Field II simulations. Here, we compared three methods (i.e., steering with 
sub-apertures, the sparse array technique, and dual-phase transmit focusing) with push 
beams of the same angles (±40°). For dual-phase transmit focusing, we applied Δϕ of 140°. 
First, steering with sub-apertures caused energy loss because of undesirable grating lobes, 
and the reduced size of sub-divided apertures yielded the lowest peak pressure in both the 
main lobe and the angular beams. In addition, although the sub-aperture approach produced 
the longest depth of focus (DOF), the larger f-number of sub-divided apertures broadened 
the lateral beam width, and thus, increased the full width at half maximum (FWHM). The 
sparse array technique yielded a narrower FWHM than those of the sub-divided apertures, 
but the peak pressure of the angular beams, compared to that of the main lobe, became less 
than half. Overall, dual-phase transmit focusing maintained the lateral beam width while 
preserving peak pressures, which could be ideal in the simultaneous creation of multi-
angular push beams. Nevertheless, further studies on optimizing the angular push beams 
are necessary for the clinical translation of this technique, because our approach distributes 
the given acoustic energy into three lobes, which lowers the magnitude of shear wave 
signals compared to single push-based SWEI approaches. 
Table 5 – Quantitative assessment results of push beams created by three methods. 
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0.36 2.21 10.82 0.20 3.30 13.54 
Sparse array 
technique 




0.42 0.91 6.43 0.42 1.65 9.56 
2.3.7 Computational Complexity 
 Computational complexity of MAC-SWEI, requiring multi-directional filtering and 
reconstruction of four SWV maps, could be one of the concerns for real-time imaging. 
However, many SWEI-based methods have already adopted (multi-) directional filtering 
to remove reflected shear waves from boundaries of inclusions or targets [27, 64, 65, 76]. 
In addition, unlike single-push SWEI methods, MAC-SWEI completes the final 
reconstruction of an SWV map within a single pushing-tracking event; if a PRF of a push 
pulse is 1 Hz, then the frame rate of SWV maps created by MAC-SWEI is also 1 Hz. 
However, in conventional SWEI methods, the frame rate could be ½ Hz to ¼ Hz 
(depending on the number of push beam applications at different locations). Thus, although 
MAC-SWEI requires four-fold more computations to create a final SWV map, it provides 
a two- to four-fold faster frame rate. Therefore, for the given frame rate of SWV images, 
both MAC-SWEI and single-push SWEI methods will have similar computational 
complexity in terms of the number of estimation of SWV maps. Furthermore, single-push 
SWEI methods could require longer overall computation times due to additional processes, 
including beamforming and image formation, for multiple sets of data acquired. 
 29 
2.4 Conclusion 
 This chapter introduced a new way of creating multi-angular push beams, referred 
to as “dual-phase transmit focusing.” By alternatively applying two phases on every other 
element, dual-phase transmit focusing efficiently and simultaneously creates one main and 
two grating lobes as pushing sources, which realizes multi-angle compound SWEI (MAC-
SWEI). We found that the phase difference Δϕ determines the energy distribution to these 
three lobes. We investigated three representative configurations with Δϕ’s of 0°, 140°, and 
180°, and quantitatively assessed the performance of MAC-SWEI using an elasticity 
phantom with a single stiff inclusion. Our results suggest that MAC-SWEI can be used to 
visualize SWV maps reliably, and with improved image quality. An additional study is 
required to optimize the dual-phase transmit focusing as the choice of optimal Δϕ may 
depend on size, shape, or location of a lesion. Thus, our future work will be focused on the 
optimization of dual-phase transmit focusing and the clinical translation of this technique.  
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CHAPTER 3. IMPACT OF DEPTH-DEPENDENT OPTICAL 
ATTENUATION ON WAVELENGTH SELECTION FOR 
SPECTROSCOPIC PHOTOACOUSTIC IMAGING 
 The chapter was reproduced and reprinted with permission from H. Yoon, G. P. 
Luke, and S. Y. Emelianov, “Impact of depth-dependent optical attenuation on wavelength 
selection for spectroscopic photoacoustic imaging”, Photoacoustics, October, 2018. The 
reference can be found in [83].  
 An optical wavelength selection method based on the stability of the absorption 
cross-section matrix to improve spectroscopic photoacoustic (sPA) imaging was recently 
introduced. However, spatially-varying chromophore concentrations cause the 
wavelength- and depth-dependent variations of the optical fluence, referred to as spectral 
coloring, which degrades the accuracy of quantitative sPA imaging. This chapter 
introduces a depth-optimized method that determines an optimal wavelength set 
minimizing an inverse of the multiplication of absorption cross-section matrix and fluence 
matrix to minimize the errors in concentration estimation. This method assumes that the 
optical fluence distribution is known or can be attained otherwise. We used a Monte Carlo 
simulation of light propagation in tissue with various depths and concentrations of deoxy-
/oxy-hemoglobin. We quantitatively compared the previous and current approaches, 
indicating that the choice of wavelength is critical, and our approach is effective especially 
when quantifying deeper imaging targets. 
3.1 Introduction 
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 Blood oxygen saturation (SO2), the ratio of oxygenated to total hemoglobin 
concentrations in the blood, provides useful functional information on many pathological 
conditions including cancer. Since oxygen deficiency (hypoxia) in a tumor is strongly 
associated with a tumor malignancy, metastasis, and resistance to various therapies, the 
non-invasive estimation of the SO2 level is essential for tumor characterization and 
treatment planning [36, 37, 84]. Naturally, to explore tumor hypoxia, researchers have 
investigated various medical imaging and sensing techniques such as needle electrodes, 
near-infrared spectroscopy (NIRS), positron emission tomography (PET), blood oxygen 
level-dependent (BOLD) magnetic resonance imaging (MRI), and electron paramagnetic 
resonance imaging (EPRI) [85, 86]. However, none of these techniques offers non-invasive 
and real-time measurements of SO2 with high sensitivity and fine spatial resolution at 
clinically relevant depths. 
 As an effective alternative, photoacoustic (PA) imaging is becoming a promising 
biomedical imaging modality since it provides high optical absorption contrast from 
endogenous chromophores and exogenous contrast agents with ultrasonic resolution [32, 
33, 87]. This ability of PA imaging shows substantial potential in the characterization of 
tumors, atherosclerotic plaque, and brain functionality [33, 88-91]. Moreover, 
spectroscopic photoacoustic (sPA) imaging can quantify the concentrations of multiple 
absorbers. Since each optical absorption spectrum is a unique function of optical 
wavelength, multiple tissue chromophores can be separated using a multi-wavelength set 
of PA images [92-94]. Thus, because of its ability to unmix concentrations of multiple 
absorbers, sPA imaging has been extensively used in many applications including the 
measurement of SO2 and nanoparticle deposition [41, 90, 95-98]. 
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 To estimate the concentrations of various absorbers, we have to solve optical and 
acoustic inverse problems [32, 95]. The solution of optical inverse problem requires a 
multi-wavelength or spectroscopic set of PA images. However, sPA imaging extends data 
acquisition time and, therefore, degrades temporal resolution and increases motion 
artifacts. In addition, a tunable laser system is less cost-effective in comparison to a small 
set of single-wavelength lasers. Thus, the careful choice of wavelengths is imperative. To 
select an optimal set of wavelengths, a method of capturing the unique spectral features of 
absorbers under a given number of wavelengths was developed previously [99]. In this 
approach, we used the stability of the absorption cross-section matrix under a 
pseudoinverse operation as a criterion and selected a set of wavelengths whose absorption 
cross-section matrix has the largest minimum singular value as the optimal set. The 
developed method showed the promising potential in the wavelength selection for in vivo 
imaging [98]. 
 Because chromophores vary spatially, optical fluence is a function of position and 
wavelength. Thus, the amount of light fluence reaching the region-of-interest (ROI) needs 
to be taken into account through analytical or numerical modeling of light transport in 
tissue. This study investigates the impact of optical wavelength selection in the presence 
of light fluence variations in tissue. Under the assumption that the fluence distribution in 
the tissue is known, we introduce a depth-optimized wavelength selection method that 
accurately estimates the concentrations of absorbers. In practice, the fluence distribution 
can be determined by an independent measurement [100, 101], or accounted for in an 
inversion scheme that uses a light transport model [95, 102-104]. For verification of our 
approach, we use a Monte Carlo (MC) simulation of light propagation in tissue with a 
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blood vessel containing various SO2 levels at multiple depths. For a quantitative evaluation, 
we compare the proposed and previous methods by applying the various levels of additive 
white Gaussian noise and computing the root-mean-square errors (RMSE) of oxy- and 
deoxy- hemoglobin concentrations. 
3.2 Theory of Spectroscopic Photoacoustic (sPA) Imaging 
The photoacoustic effect describes the generation of sound waves following light 
absorption and thermoelastic expansion, resulting in a peak local pressure rise, p0. Here, p0 
is a function of optical wavelength λ and determined by the combination of three quantities 
(Grüneisen coefficient  (the PA efficiency), optical absorption coefficienta,  and  light 
fluence ) as follows [95]: 
 𝑝0(𝜆) = Г𝜇𝑎(𝜆)Φ(𝜆). (11) 
 Three wavelength-dependent quantities and the Grüneisen coefficient in Equation 
11 (i.e., p0, a, and ) are all also spatially variant, but for the simplicity, their position 
vector is not used in this chapter. Here, a is generally a linear combination of absorber 
concentrations, and thus, can be represented as 
 




where I is the number of absorbers of interest, i is the molar absorption cross section of 
the ith absorber, and Ci is the concentration of the ith absorber. We assume that the 
Grüneisen coefficient is constant and the light fluence distribution is known. In practice, 
modeling of light fluence is challenging because of unknown optical properties of tissue in 
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general [95, 102, 105-108]. In addition, although the reconstruction of the acoustic signals 
received by an ultrasound transducer, depending on tissue heterogeneity, acoustic 
properties, and detector geometry, is not trivial, here we assume that p0 can be accurately 
reconstructed [109]. Then, the local ultrasound pressure (p0 in Equation 11) can be 
converted to a,est by assuming that the light fluence distribution over wavelength at every 






 Then, by combining Equation 12 and 13 and using vector notation, a set of linear 
equations is formulated as 
 𝛍𝐚,𝐞𝐬𝐭 = 𝛆𝐂, (14) 
where a,est is the M-by-1 vector with reconstructed absorption coefficients (M is the 
number of wavelengths used in sPA imaging),  is the M-by-I absorption cross-section 
matrix, and C is the I-by-1 vector of absorber concentrations (I is again the number of 
optical absorbers of interest). Then, when M is equal to or greater than I, the concentrations 
can be computed by 
 𝐂𝐞𝐬𝐭 = 𝛆
+𝛍𝐚,𝐞𝐬𝐭, (15) 
where Cest is the estimates of true concentrations (C) and  is the pseudoinverse of . Here, 
to prevent concentration estimates from becoming less than 0 or larger than 1, further 
constraints, including a non-negativity constraint, can be applied in Equation 15 [96, 110]. 
3.3 Materials and Methods 
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3.3.1 A Depth-Optimized Wavelength Selection Method 
 Although the use of extra wavelengths typically allows us to obtain more precise 
estimates of concentrations in the presence of noise (but, in the absence of motion), it is 
desirable to keep the number of wavelengths to as few as possible to avoid motion artifacts, 
to improve temporal resolution, and to accelerate image acquisitions. To reduce the 
redundancy in the choice of wavelengths while preserving accuracy, this study introduces 
an algorithm that finds an optimal set of wavelengths for accurate concentration estimation. 
Then, with the consideration of the thermal and electronic noise in the system, local 
acoustic pressure p0, in Equation 11 can be redefined by adding white Gaussian random 
noise n: 
 𝑝0(𝜆) = Г𝜇𝑎(𝜆)Φ(𝜆) + 𝑛. (16) 








 By presenting Equation 17 as a simpler vector form, we obtain the following 
equation: 
 





where a,n is the M-by-1 vector of the reconstructed absorption coefficients, nis the M-by-
1 noise vector, and Dis the M-by-M diagonal matrix where D(j,j) = (j). Like Equation 
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15, the noise-corrupted estimates of concentrations Cest,n can be obtained by taking the 







 From Equation 19, Cest,n becomes Cest if and only if the noise-related second term 
becomes 0. Therefore, to remove errors in all concentrations, the following equation needs 
to be minimized: 
 ‖𝛆+𝚽𝐃
−𝟏𝐧‖. (20) 




where M is an M-by-1 vector containing all 1’s. Our goal is to find a set of wavelengths 
that minimizes the Equation 21 under the given number of wavelengths (M). In other 
words, a set of wavelengths minimizing Equation 21 (i.e., the noise-related second term in 
equation (9)) makes Cest,n as close as to Cest (i.e., the noise-free ideal concentration 
estimates). In addition, it is clear that the Equation 21 relies on two quantities:  (i.e., the 
pseudoinverse of absorption cross-section matrixand 𝚽D
−1 (i.e., the inverse of diagonal 
fluence matrix). Given the absorbers of interest, the absorption cross-section matrix can be 
assumed to be known, but the fluence matrix is generally unknown. Thus, in order to solve 
the Equation 21, the fluence matrix should be modeled in practice. In this study, a Monte 
Carlo model was used to model the fluence as described below in the following section. 
Note that accurate modeling of fluence distribution still remains a concern, which impacts 
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the accuracy of our method.  In the minimization process, because the wavelengths 
typically used in sPA imaging are finite and discrete (wavelengths from 680 nm to 970 nm 
with a one nm step size are used in this study), every possible set of wavelengths was 
applied to find an optimal set of wavelengths where the objective function (i.e., Equation 
21) is globally minimized. Here, note that 1
DΦε
  in Equation 21 can be rewritten as  εΦD  
and the term εΦD  is maximized in the method to minimize the noise-related error in 
solving a spectral unmixing problem. Here, note that after a set of optimal wavelengths is 
selected by this approach, any spectral unmixing methods can be applied to obtain the 
concentrations of chromophores. 
3.3.2 Monte Carlo Study Parameters 
 To investigate our approach under various conditions, the recently introduced MC 
program (mcxyz.c) [109] was used, which allows us to obtain precise optical fluence maps, 
including a blood vessel with various SO2 levels. Figure 11 shows tissue models that 
consist of air, epidermis (600-µm-thickness), dermis (with a blood volume fraction of 0.2 
%), and blood. The blood vessel (500-µm-diameter) was placed at three depths (0.4 cm, 
1.0 cm, and 1.6 cm) with five SO2 levels (0.00, 0.25, 0.50, 0.75, and 1.00). Here, the SO2 
level of blood in dermis is the same as that in the blood vessel. The laser beam applied was 
uniform and had a radius of 0.4 cm. Figure 12 shows the absorption coefficients of oxy-, 
deoxy-hemoglobin, water, and melanin used in our study. For oxy- and deoxy-hemoglobin, 
typical values of the concentration ratio of hemoglobin in blood (150 g/L) and molecular 
weight of hemoglobin (64,500 g/mol) were used. The software and the detailed optical 
parameters of the tissue model, including anisotropy, absorption, and scattering 
coefficients, were obtained from the OMLC website (please refer to makeTissueList.m and 
spectralLIB.mat files at https://omlc.org/software/mc/mcxyz/index.html). Tissue 
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parameters for epidermis, dermis, blood, air, and water used in this study were the same as 
those listed in the website while SO2 levels were varied. 
 
Figure 11 – Tissue models with air, epidermis, dermis, and 500-µm-diameter blood 
vessels at three depths: (a) 0.4 cm, (b) 1.0 cm, and (c) 1.6 cm. 
 
Figure 12 – Absorption coefficients of oxy- and deoxy-hemoglobin, water, and 
melanin (data obtained from the spectralLIB.mat file available at 
https://omlc.org/software/mc/mcxyz/index.html). 
 To collect the light fluence from the program, a three-dimensional array with 
800x640x2 bins, each 25 µm was created. The optical wavelengths of light ranged from 
680 nm to 970 nm with a one nm step size (thus, 291 wavelengths). Therefore, 291x5x3 
light fluence maps corresponding to the number of wavelengths, SO2 levels, and vessel 
positions, respectively were acquired. Each simulation time of the light fluence of an 
individual wavelength was 90 minutes (resulting in an average number of photons of 
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1.5x106), so this study required a 291x5x3x1.5-hour simulation. To expedite the 
simulation, 15 cores of an Intel Xeon processor (Intel Corp., Santa Clara, CA) were utilized 
simultaneously, allowing us to simulate all fluence maps in 291x1.5 hours. Overall, the 
MC program was used to acquire various optical fluence maps with multiple wavelengths 
(680 nm to 970 nm), five SO2 levels (0.00, 0.25, 0.50, 0.75, and 1.00), three depths of a 
blood vessel (0.4 cm, 1.0 cm, and 1.6 cm), which took approximately 18 days. 
3.3.3 Data Handling 
 After obtaining optical fluence maps, the fluence signals in each blood vessel at 
each individual wavelength were first averaged and one-dimensional optical fluence 
spectra with respect to the wavelength was constructed. Then, the averaged optical fluence 
signals were multiplied by the known absorption coefficients, which reconstructs the PA 
spectrum. To build the noise-added PA spectrum as in Equation 16, various amounts of 
zero mean white Gaussian random noise were generated and added to the reconstructed PA 
spectrum. In this study, we used the simple noise model by assuming the frequency 
response of the transducer is ideally flat as typically adopted in other studies for brevity 
[111, 112]. Here, the standard deviations (STD) of noise ranged from 0.0 to 0.1, which 
results in a reasonably wide range of the signal-to-noise ratio (SNR) in the PA spectrum 
(about 10.7 dB to 85.1 dB. See Figure 17.). In addition, to obtain statistical results, adding 
this random noise onto the PA spectrum and estimating concentrations were repeated 104 
times. 
3.3.4 Assessment 
 For the quantitative evaluation, this study used the root-mean-squared error 
(RMSE) of the concentration estimates (i.e., the concentrations of oxy-hemoglobin (HbO2), 









where Cest,n represents a concentration estimate, C is a ground-truth concentration set in the 
MC simulation, and T is the number of noise trials (here, T=104). Note that Cest,n in Equation 
22 is any element of Cest,n in Equation 19. The RMSE of two estimates: the concentrations 
of HbO2 and Hb used to quantify SO2 at various vessel depths and SO2 levels as a function 
of the noise STD were computed. To investigate the robustness of our method under the 
various amounts of noise, the white Gaussian random noise was repeatedly applied. 
 In this study, M was set to two (i.e., the minimum number of wavelengths to identify 
the distribution of two chromophores). Given this condition, we compared two wavelength 
selection methods: the proposed noise minimization approach and the previous minimum 
singular value-based approach [99]. Here, these methods are referred to as nmin, and σmin, 
respectively. In addition, we applied two methods to reconstruct concentrations: linear least 
squares with non-negativity constraints (the lsqnonneg function in MATLAB) and without 
any constraints (referred to as CLLS and LLS, respectively). Although two linear least 
squares methods were used in this research, both wavelength selection methods are not 
restricted to any spectral unmixing method. In summary, two wavelength selection 
approaches (nmin and σmin) with and without non-negativity constraints (thus, total four 
methods) were used to estimate the concentrations of HbO2 and Hb at three depths of a 
vessel and five SO2 levels as a function of noise levels. For quantitative comparisons, the 
RMSE of the estimates and the average of corresponding SO2 were computed. 
3.4 Results and Discussion 
 Figure 13, Figure 14, and Figure 15 show the optical fluence maps containing a 
blood vessel at three depths: 0.4 cm, 1.0 cm, and 1.6 cm. All the fluence maps (in the unit 
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of J/cm2 per J delivered or 1/cm2) are displayed on a logarithmic scale. The rows of each 
figure represent the fluence maps of three representative optical wavelengths (680 nm, 875 
nm, and 970 nm) selected from 291 maps, which range from 680 nm to 970 nm with a 1-
nm step size. The columns represent five SO2 levels (0.00, 0.25, 0.50, 0.75, and 1.00) in 
blood vessels. Figure 13, Figure 14, and Figure 15 show that the optical fluence varies 
according to the optical wavelength and the SO2 level. These variations in the fluence 
indicate that the choice of wavelengths affects the strength of the fluence, which determines 
the SNR. Furthermore, because of light attenuation, the deeper the vessel is located in 
tissue, the more the overall fluence decreases. Therefore, the optical wavelength selection 
becomes more challenging and crucial, particularly when imaging deeply located targets. 
 To investigate the wavelength- and depth-dependent characteristics of optical 
fluence, we first averaged the fluence signals of each individual wavelength within each 
blood vessel as one-dimensional optical fluence functions with respect to wavelengths 
(Figure 16). According to optical wavelength, SO2, and depth, the fluence signals vary 
substantially. As a notable example, the fluence patterns of 0.4-cm and 1.6-cm vessels 
clearly differ. In contrast to the fluence at the 0.4-cm vessel, the fluence at the 1.6-cm vessel 
abruptly decreases and becomes negligible as the wavelength increases. This observation 
suggests that avoiding using higher wavelengths (> 950 nm) when estimating SO2 in the 
far region is desirable. 
 To construct the noise-added PA spectra in Equation 16 and to investigate the 
robustness of our approach, we added various amounts of white Gaussian random noise to 
PA spectra reconstructed from the averaged one-dimensional fluence signals and the 
known absorption coefficients. The standard deviations (STDs) of noise spanning from 0 
to 0.1 created the wide range of SNR. We repeated this process 104 times to find the mean 
SNRs of the PA spectra. Figure 17 shows the mean SNRs over the noise STD. As the noise 
STD increases, the mean SNRs decrease. In addition, three mean SNR functions are plotted 
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according to three depths of a vessel. The deeper the vessel, the more SNR decreases. After 
all, we use these noise-added PA spectra to assess two wavelength selection methods (nmin 
and σmin). 
 
Figure 13 – Representative optical fluence maps of the tissue model containing a blood 
vessel at a 0.4 cm depth. Rows represent wavelengths of light, 680, 875, and 970 nm, 
and columns represent five levels of oxygen saturation in the blood vessel, 0.00, 0.25, 
0.50, 0.75, and 1.00. The unit of fluence Φ is J/m2 per J delivered or 1/m2. 
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Figure 14 – Representative optical fluence maps of the tissue model containing a blood 
vessel at a 1.0 cm depth. Rows represent wavelengths of light, 680, 875, and 970 nm, 
and columns represent five levels of oxygen saturation in the blood vessel, 0.00, 0.25, 
0.50, 0.75, and 1.00. The unit of fluence Φ is J/m2 per J delivered or 1/m2. 
 To estimate two concentrations of HbO2 and Hb to quantify SO2 levels, this study 
uses two optical wavelengths (M=2, the minimum number of wavelengths to solve the 
optical inverse problem.) selected by the proposed and the previous methods: nmin and σmin. 
nmin finds two wavelengths that minimize the added noise term whereas σmin finds two 
wavelengths that maximize the minimum singular value of the absorption cross-section 
matrix. Therefore, the former minimizes the noise-related errors, and the latter allows the 
selected absorption cross-section matrix to have unique spectral features. As a result, σmin 
selects two wavelengths: 680 nm and 970 nm. Here, since σmin relies on only the stability 
of absorption cross-section matrix, we use the same set of wavelengths, regardless of the 
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depth or the concentration of chromophores. However, since nmin exploits the optical 
fluence distribution and the optical fluence varies according to the imaging depth or the 
concentration of absorbers, our approach adaptively offers optimal sets of wavelengths as 
presented in Table 6. 
 
Figure 15 – Representative optical fluence maps of the tissue model containing a blood 
vessel at a 1.6 cm depth. Rows represent wavelengths of light, 680, 875, and 970 nm, 
and columns represent five levels of oxygen saturation in the blood vessel, 0.00, 0.25, 
0.50, 0.75, and 1.00. The unit of fluence Φ is J/m2 per J delivered or 1/m2. 
 Table 6 describes the selected sets of wavelengths via the proposed method (nmin). 
First, where the vessel depth is 0.4 cm, the PA spectrum has relatively high SNR as shown 
in Figure 17, and the optical fluence hardly fluctuates or decreases over the wavelength as 
shown in Figure 16. Therefore, most of the sets of wavelengths (first column in Table 6) 
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are similar to those (680 nm and 970 nm) chosen by σmin. Nevertheless, small shifts in the 
wavelength are observable. As SO2 decreases from 1.00 to 0.00, the optical fluence at 680 
nm decreases. Hence, nmin tends to select the wavelength with higher optical fluence to 
satisfy the Equation 21. As a result, the first wavelength increases from 681 nm to 692 nm 
as SO2 changes from 1.00 to 0.00. The second wavelengths used for the 0.4-cm vessel 
mostly remain at around 970 nm, except when SO2 is 1.00. Since the optical fluence at 970 
nm decreases gradually when SO2 increases. Thus, when SO2 is 1.00, the wavelength 
moves to 909 nm, which indicates that the gain in the optical fluence starts to outweigh the 
loss in spectral distinction. Similarly, as the depth of a vessel increases, nmin selects shorter 
wavelengths as the second wavelengths. 
 
Figure 16 – One-dimensional averaged optical fluence signals in three vessel depths 
at (a) 0.4 cm, (b) 1.0 cm, and (c) 1.6 cm at 0 cm in the lateral direction as a function 
of wavelength. 
 Figure 18 and Figure 19 show the RMSE of estimated HbO2 and Hb concentrations 
under various SO2 levels and vessel depths. This study uses two wavelength selection 
methods (nmin and σmin) with two constraints (with and without the non-negativity 
constraint) (i.e., four methods: nmin+LLS, nmin+CLLS, σmin+LLS, and σmin+CLLS). The 
RMSE is negligible in both HbO2 and Hb at the 0.4-cm depth vessel, since as illustrated in 
 46 
Figure 17, the overall SNR is sufficiently large at 0.4 cm over all wavelengths (> 40 dB). 
Furthermore, since the choices of wavelengths by two wavelength selection methods (nmin 
and σmin) are almost identical when the vessel is located at 0.4 cm, the RMSE differences 
between the two methods are minor, except when SO2 is 1.00. However, the deeper the 
vessel is located, the more the overall SNR decreases, and thus, the RMSE becomes larger. 
In addition, from the 1.6-cm vessel, we can observe the largest gap between the RSME of 
the two wavelength selection methods, which suggests that the wavelength choice is critical 
in far-depth imaging. Commonly, the non-negativity constraint (CLLS) produces more 
precise estimates in terms of RMSE. 
 
Figure 17 – Mean SNRs of PA spectrum in blood vessels at three depths (0.4 cm, 1.0 
cm, and 1.6 cm) as a function of noise STD. 
 In Figure 20, we compute mean SO2 levels from the concentration estimates of 
HbO2 an Hb. Here, since any negative estimate in the concentration of HbO2 or Hb causes 
amplified or negative SO2 values, the non-negativity constraint is desirable in the 
estimation of SO2. However, the non-negativity constraint results in a bias in SO2 when 
SO2 is 0.00 or 1.00. Overall, as the vessel depth increases, the accuracy in mean SO2 levels 
degrades, shown in Figure 10. Particularly, when the noise STD is larger than 0.01 at the 
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1.6-cm vessel (that is, SNR < 30 dB), the σmin method without the non-negativity constraint 
(i.e., σmin+LLS) fails to reconstruct reliable SO2 levels. The non-negativity constraint 
partially improves accuracy but still yields substantial errors. However, nmin stably 
measures SO2 levels regardless of vessel depths, constraints, and concentrations. 
Table 6 – Two (M=2) selected wavelengths (nm) used for estimating SO2 by the 
proposed approach (nmin) at three Vessel depths under five SO2 levels. 
SO2 
Vessel depth 
0.4 cm 1.0 cm 1.6 cm 
0.00 692, 970 688, 895 681, 882 
0.25 694, 969 683, 887 687, 887 
0.50 683, 970 684, 909 693, 881 
0.75 681, 970 680, 906 684, 878 
1.00 681, 909 682, 887 680, 893 
 
Figure 18 – RMSE of estimated HbO2 concentrations from four methods: σmin+LLS, 
σmin+CLLS, nmin+LLS, and nmin+CLLS with respect to the noise STD. Rows represent 
three vessel depths (0.4 cm, 1.0 cm, and 1.6 cm). Columns represent five levels of SO2 
(0.00, 0.25, 0.50, 0.75, and 1.00). 
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Figure 19 – RMSE of estimated Hb concentrations from four methods: σmin+LLS, 
σmin+CLLS, nmin+LLS, and nmin+CLLS with respect to the noise STD. Rows represent 
three vessel depths (0.4 cm, 1.0 cm, and 1.6 cm). Columns represent five levels of SO2 
(0.00, 0.25, 0.50, 0.75, and 1.00). 
 
Figure 20 – Estimated mean SO2 by four methods: σmin+LLS, σmin+CLLS, nmin+LLS, 
and nmin+CLLS with respect to the noise STD. Rows represent three vessel depths 
(0.4 cm, 1.0 cm, and 1.6 cm). Columns represent five levels of SO2 (0.00, 0.25, 0.50, 
0.75, and 1.00). 
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 We investigated the effect of the choice of optical wavelengths in the estimation of 
SO2 using sPA imaging in the presence of wavelength-dependent, spatially-variant fluence 
through the simulation. Different amount of additive white random noise was applied to 
demonstrate the changes in desired optical wavelengths, showing that the current method 
outperforms the previous method especially when the SNR is low (i.e., the noise STD is 
high). In addition, the wavelength choices in Table 6 indicate that for deeper vessel (i.e., 
the SNR becomes lower), the wavelengths selected with our method are increasingly 
different from those estimated using the previous method, resulting in improved accuracy 
in SO2 estimation (note that the wavelength sets in Table 6 are only optimal in our 
simulation settings, not optimal in general). Thus, for sPA images with low signal and/or 
high noise, our method finds a more optimal set of optical wavelengths. However, the noise 
model used in our study does not reflect all noise components present in sPA imaging. 
Thus, a future study should include other noise sources, such as thermal acoustic noise 
from the medium and thermal noise from the transducer, to make the model more realistic 
[113]. 
 The results clearly show that the imaging depth and tissue properties play a 
significant role in the optimal wavelength selection for sPA imaging. As researchers seek 
to reduce the cost and/or improve the temporal resolution of  sPA imaging systems, using 
only small subset of the optical spectrum is an appealing option. In practice, the specific 
choice of imaging wavelengths is nontrivial and application-dependent. In this work, we 
assumed that the optical fluence distribution is known. In this case, our method selects 
wavelengths capable of achieving accurate sPA images of hemoglobin relatively deep in 
tissue. In practice, because spatially-varying optical properties of tissue are unknown, 
successful modeling of the optical fluence distribution is often challenging and requires 
several assumptions, such as the number and a type of absorbers and the scattering 
coefficients. Therefore, the selected wavelengths found by our method likely to be 
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suboptimal. These results indicate that extensive analysis of a variety of tissue properties 
must be performed prior to selecting a subset of the available wavelengths. One additional 
consideration is the maximum safe level of laser exposure [114]. In the wavelength range 
from 680 nm to 970 nm, longer wavelengths allow us to use higher laser energy and achieve 
higher SNR, which could result more accurate sPA images. 
 This study assumed that the acoustic inversion problem to reconstruct the local PA 
spectrum from the received PA spectrum can be solved. However, to reconstruct acoustic 
pressure generated in local absorbers accurately, we should consider heterogeneous tissue, 
bandlimited ultrasound detectors, and other physical limitations [108]. In reality, the 
heterogeneity of tissue may cause variations in the speed of sound, resulting in phase 
aberration [115]. This degrades the image quality as well as the accuracy in concentration 
estimation. Thus, the accurate modeling of non-homogenous tissue properties should be 
considered when reconstructing PA images. In addition, because the received PA signals 
are inherently wide band and noisy, the sensitivity of the ultrasound transducer is crucial. 
The limited bandwidth and SNR of the PA spectrum affect the resolution and the accuracy 
of SO2 estimation [43]. Furthermore, because of frequency-dependent attenuation of 
acoustic waves, as the imaging depth increases, the center frequency of the acoustic wave 
downshifts and its bandwidth becomes narrow, degrading the resolution and the SNR. 
Moreover, using data acquired with a linear array transducer, the limited-view tomographic 
reconstruction leads to the artifacts in the local PA reconstruction. Finally, the 
reverberation artifact (or reflection artifact), mainly caused by strong PA signals generated 
from superficial optical absorbers, is another issue in sPA imaging because it significantly 
limits the image contrast and the imaging depth [116]. 
3.5 Conclusion 
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 Through the simulation study, we have shown that the wavelength selection for the 
SO2 estimation in sPA imaging is affected by the corresponding wavelength-dependent 
optical fluence distribution. To improve the SO2 estimation capability, this chapter has 
introduced the depth-optimized wavelength selection method, which allows us to obtain 
the concentration estimates with higher accuracy. Assuming that the wavelength-
dependent, spatially-variant optical fluence distribution can be reliably obtained, this 
approach finds a set of wavelengths, which minimizes the noise-related errors in the 
concentration estimates. Through the MC simulation of light propagation in tissue, we have 
investigated the effect of various imaging parameters, including the depth and the 
concentrations of chromophores. The quantitative assessment using RMSE showed that the 
proposed approach robustly and accurately estimated SO2 over the previous method. This 
study indicates that the choice of wavelength in sPA imaging is critical, and our depth-
optimized method could be effective, especially when quantifying deeper agents.  
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CHAPTER 4. CONTRAST-ENHANCED ULTRASOUND 
IMAGING IN VIVO WITH LASER-ACTIVATED 
NANODROPLETS 
 The chapter was reproduced and reprinted with permission from H. Yoon, S. K. 
Yarmoska, A. S. Hannah, C. Yoon, K. A. Hallam, and S. Y. Emelianov, “Contrast-
enhanced ultrasound imaging in vivo with laser-activated nanodroplets”, Medical Physics, 
vol. 44, no. 7, pp. 3444-3449, July 2017. © 2017 American Association of Physicists in 
Medicine. The reference can be found in [56]. 
 This chapter introduces a real-time contrast-enhanced ultrasound imaging method 
with recently developed laser-activated nanodroplets (LANDs), a new class of phase-
change nanometer-scale contrast agents that provides perceptible, sustained high-contrast 
with ultrasound. In response to pulsed laser irradiation, the LANDs—, which contain liquid 
perfluorohexane and optical fuses—blink (vaporize and recondense). That is, they change 
their state from liquid nanodroplets to gas microbubbles, and then back to liquid 
nanodroplets. In their gaseous microbubble state, the LANDs provide high-contrast 
ultrasound, but the microbubbles formed in situ typically recondense in tens of 
milliseconds. As a result, LAND visualization by standard, real-time ultrasound is limited. 
However, the periodic optical triggering of LANDs allows us to observe corresponding 
transient, periodic changes in ultrasound contrast. This study formulates a probability 
function that measures how ultrasound temporal signals vary in periodicity. Then, the 
estimated probability is mapped onto a B-scan image to construct a LAND-localized, 
contrast-enhanced image. We verified our method through phantom and in vivo 
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experiments using an ultrasound system (Vevo 2100, FUJIFILM VisualSonics, Inc., 
Toronto, ON, Canada) operating with a 40-MHz linear array and interfaced with a 10 Hz 
Nd:YAG laser (Phocus Mobile, Opotek Inc., Carlsbad, CA, USA) operating at the 
fundamental 1064 nm wavelength. From the phantom study, the results showed 
improvements in the contrast-to-noise ratio of our approach over conventional ultrasound 
ranging from 129% to 267%, with corresponding execution times of 0.10 to 0.29 s, 
meaning that the developed method is computationally efficient while yielding high-
contrast ultrasound. Furthermore, in vivo sentinel lymph node (SLN) imaging results 
demonstrated that our technique could accurately identify the SLN. The results indicate 
that our approach enables efficient and robust LAND localization in real time with 
substantially improved contrast, which is essential for the successful translation of this 
contrast agent platform to clinical settings. 
4.1 Introduction 
 Cancer is the second leading cause of death in the United States, and most cancer-
related deaths are highly associated with metastasis [117, 118]. Therefore, detecting and 
assessing the sentinel lymph node (SLN), which is the first lymph node to which cancer 
cells drain from a primary tumor,  is crucial. To identify the SLN, researchers have explored 
numerous biomedical imaging techniques [41, 98, 119-124]. Classically, 
lymphoscintigraphy with radiocolloid injection has been widely used for preoperative 
lymph node imaging, but its imaging resolution is relatively low [121]. Magnetic resonance 
imaging (MRI) has shown promising results for nodal staging, but MRI is not cost effective 
and imaging lymph nodes during surgery and/or biopsies is challenging [122]. In addition, 
although positron emission tomography/computed tomography (PET/CT) has shown 
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potential in preoperative scanning of lymph nodes, its sensitivity and specificity in 
identifying SLN is lower than those of lymphoscintigraphy or MRI [125]. Ultrasound is a 
cost-effective and non-invasive imaging modality that is able to guide SLN biopsies in 
real-time. Although ultrasound can be used to identify lymph nodes, the contrast between 
lymph nodes and the surrounding background is limited, and ultrasound alone cannot 
visualize which node receives drainage from the tumor. Accordingly, microbubbles have 
been used to improve contrast, but their relatively large size (a few microns) impedes their 
influx into the lymph node [126, 127]. In addition, their circulation time is relatively short 
(a few minutes), limiting the duration of imaging sessions [45]. 
 To address these limitations of microbubbles, phase-changing nanodroplets that can 
be activated either acoustically or optically have been intensively investigated [48, 49, 128-
131]. Because they remain in a stable liquid state until they are triggered, nanodroplets can 
circulate relatively longer and remain small enough to extravasate from tumor 
neovasculature. Once vaporized in response to an acoustic or optical trigger, nanodroplets 
become gaseous microbubbles, providing high-contrast ultrasound similar to conventional 
microbubbles. However, because nanodroplets usually consist of low-boiling-point 
materials (e.g., perfluoropentane (29°C) or perfluorobutane (−1°C)), they do not 
recondense back to the original liquid state after activation. More recently, our group and 
others have developed laser-activated nanodroplets (LANDs) containing liquid 
perfluorohexane and optical dye. LANDs repeatedly vaporize and recondense because the 
boiling point of perfluorohexane (56°C) is higher than physiological temperature (37°C) 
[55, 132, 133]. This unique, repeatable phase-changing property of LANDs has enabled or 
improved many applications, including super-resolution imaging, background-free 
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imaging, and photoacoustic imaging [55, 132, 133]. Figure 21 shows the blinking dynamics 
of the LANDs. Before optical triggering, the LANDs remain liquid nanodroplets, 
producing very limited ultrasound echoes. However, once activated by pulsed laser 
irradiation, the LANDs rapidly vaporize into gaseous microbubbles in situ, generating 
hyperechoic ultrasound signals until the LANDs completely recondense [49, 55, 129, 133]. 
However, their gaseous period is relatively transient (several to hundreds of milliseconds), 
which limits human perception of LAND-based contrast [133]. 
 
Figure 21 – Vaporization and recondensation of laser-activated nanodroplets 
(LANDs) in response to an optical trigger.  When activated, LANDs immediately 
produce strong ultrasound signals, which decrease as the LANDs recondense to 
native, liquid droplets. 
 To overcome this limitation and to provide perceptible, sustainable LAND-based 
contrast in ultrasound, this work has developed an imaging method that effectively 
localizes the LANDs with high frame rate ultrasound imaging. In the method, we activate 
the LANDs periodically and capture the periodic blinking LANDs in ultrasound images, 
enabling the development of a fast, robust LAND-localization algorithm. 
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4.2 Materials and Methods 
4.2.1 Localization of Perfluorohexane Nanodroplets (PFHnDs) 
 This study introduces a novel, contrast-enhanced imaging method that uses high 
frame rate ultrasound imaging to localize LANDs. This real-time imaging method is 
clinically applicable and provides superior contrast to conventional ultrasound. As 
illustrated in Figure 22, our approach is based on LAND injection and optical activation, 
both of which are essential to the creation of contrast-enhanced LAND frames. Before 
injecting LANDs and initiating the laser, no localized LANDs are observable in contrast-
enhanced frames. Without an optical trigger, localized LAND frames produce nearly 
imperceptible contrast because the LANDs have not vaporized and thus remain liquid 
droplets. However, once the pulsed laser irradiates local tissue containing LANDs, the 
vaporized particles become hyperechoic, allowing for construction of contrast-enhanced 
LAND images (yellow frames in Figure 22). The recondensation process, however, is 
relatively fast; so to provide sustained contrast-enhanced imaging, this method uniquely 
exploits the periodic, repeated blinking in our LAND-localization algorithm. Overall, our 
imaging protocol reconstructs contrast-enhanced LAND image frames from the acquired 
ultrasound data at the rate of the pulse repetition frequency (PRF) of the laser. Fortunately, 
it does not require any sophisticated synchronization between the laser and the ultrasound 
systems, indicating that this approach is not limited in its utility. Until several laser pulses 
(usually, 3 to 5) activate the LANDs, it is only possible to build incomplete, transient 
LAND frames (blue). Yet after triggering several times, fully contrast-enhanced LAND 
frames (green) can be achieved. 
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Figure 22 – An imaging configuration for the localization of LANDs.  After both 
injecting and triggering LANDs, this algorithm can reconstruct contrast-enhanced 
LAND image frames at the pulse repetition frequency of a laser system. 
 The crux of the LAND localization method is that if a pixel in an image contains 
LANDs and the PRF of the laser pulses is constant, then we can induce repeated, periodic 
blinking of LANDs corresponding to this PRF. Thus, the temporal ultrasound signal for 
this pixel will contain regularly spaced peaks if the frame rate of ultrasound is also kept 
constant. The localization method assesses the consistency of the resultant peaks in 
ultrasound frames after tissue has been irradiated with multiple laser pulses. The PRF of 
the laser is defined as M and the frame rate of ultrasound is defined as R. Thus, every N 
frames (N=R/M) a single strong signal peak from the optically triggered LANDs is 
observed, as this corresponds to the ultrasound frame at which the LANDs are vaporized. 
Therefore, when irradiating with L laser pulses, L peaks occur. These L peaks here are 
recorded in L sets of N ultrasound frames (i.e., L∙N ultrasound frames contain L peaks). 
The positions of these peaks can be any integer between 1 and N, as every set consists of 
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N frames and one of these N frames will include the corresponding peak. For every pixel 
of interest in the image, the set S, containing L positions of peaks, is defined by 
 𝑆 = {𝑠1, 𝑠2, … , 𝑠𝐿}, (23) 
where s1, s2, … , sL are positions of peaks created by L number of laser pulses. Each peak 
is detected using a simple gradient operation. Then, a cost function with absolute 
differences of all two-combinations from S is defined by 




where j and k are 1, 2, …, L and j ≠ k. The cost function e(i) in Equation 24 contains 
differences between peak positions from all possible pairs of two. Only image pixels 
containing the LANDs can present periodically blinking periodic ultrasound, which results 
in small e(i)’s because these peaks are detected repeatedly and consistently. Therefore, this 
method counts the number of e(i)’s less than or equal to d, where d is a threshold that 
determines the sensitivity of the algorithm, as c(i) by 
 
𝑐(𝑖) = {
1,   𝑖𝑓 𝑒(𝑖) ≤ 𝑑
0,   𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒




 Finally, this method formulates a probability function PLAND presenting the 















where the denominator is the number of all two-combinations of L and the numerator is 
the number of two-combinations whose absolute difference is less than or equal to d. Thus, 
the probability function defined in Equation 26 represents how regularly peaks occur in the 
pixel of interest. In summary, to localize the LANDs for each pixel, this method measures 
how mutually close the detected L peaks are to temporal ultrasound sequences. The 
estimated probability in Equation 26 is displayed on each pixel of a contrast-enhanced 
LAND frame, indicating the localizability of LANDs. 
4.2.2 Experimental Set-Up 
 We synthesized the LANDs, consisting of an optical dye (Epolight 3072, Epolin, 
Inc., Newark, NJ, USA), liquid perfluorohexane (FluoroMed, L.P., Round Rock, TX, 
USA), an aqueous fluorosurfactant (Zonyl FSO, Sigma-Aldrich, St. Louis, MO, USA), and 
deionized water, following detailed procedures from our previous work [133]. Briefly, we 
first dissolved 1 mg of dye in 250 μL of perfluorohexane solution and sonicated the solution 
for 30 s. Then, we mixed this solution and a mixture of 2.5 mL deionized water and 0.5 
mL 1% v/v aqueous fluorosurfactant. We vortexed the solution for 10 s and sonicated it 
again for 5 minutes in a water bath. Finally, we washed the synthesized LANDs by 
centrifuging for 5 minutes at 1,000 relative centrifugal force (rcf) and resuspending in fresh 
deionized water. The diameter of the synthesized LANDs was 300 nm, as measured by a 
dynamic light scattering instrument (Zetasizer Nano ZS, Malvern Instruments, Malvern, 
Worcestershire, UK). 
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 For our phantom and in vivo SLN imaging studies, we used a preclinical ultrasound 
system (Vevo 2100, FUJIFILM VisualSonics Inc., Toronto, ON, Canada) with a 40-MHz 
linear array transducer. The frame rate of ultrasound imaging was 288 Hz. To activate the 
LANDs, we used a 10-Hz Nd:YAG (neodymium-doped yttrium aluminium garnet) laser 
(Phocus, Opotek Inc., Carlsbad, CA, USA) at its fundamental 1064-nm wavelength, 
without synchronization with the ultrasound system. We acquired ultrasound images for 
approximately 2 s, and thus, several tens of laser pulses could be delivered per ultrasound 
acquisition. The measured optical fluence was 50 mJ/cm2, far below the ANSI limit (100 
mJ/cm2) for safety [114]. 
 We fabricated a tissue-mimicking phantom containing a cylindrical LAND-labeled 
inclusion and a homogeneous background. The phantom consisted of 21 mL of 40% 
polyacrylamide (Thermo Fisher Scientific, Walthan, MA, USA), 850 μL of 10% aqueous 
ammonium persulfate (Sigma-Aldrich, St. Louis, MO, USA) solution, 106 μL of TEMED 
(Sigma-Aldrich, St. Louis, MO, USA), 0.2% w/w silica particles (U.S. Silica, Hurtsboro, 
AL, USA), 0.01% w/w graphite particles (Dixon Ticonderoga, Lake Mary, FL, USA), and 
64 mL of deionized water. Detailed procedures can be found in [133]. Only the inclusion 
contained 0.1% v/v LANDs. Our in vivo study was performed under protocols approved 
by the Institutional Animal Care and Use Committee at The University of Texas at Austin. 
A BALB/c nu/nu mouse (Charles River Laboratories, Inc., Wilmington, MA, USA) was 
anesthetized and injected submucosally through the tongue with 40 µL of LANDs using a 
30-gauge needle. Then, we allowed the LANDs to drain for 30 minutes and imaged the 
cervical lymph nodes in the mouse’s neck. After imaging, we immediately euthanized the 
mouse. 
 We collected two-dimensional ultrasound IQ sequences and processed the data with 
custom-written codes using MATLAB (The MathWorks, Inc., Natick, MA, USA). When 
reconstructing LAND frames, we varied the value of L (i.e., the number of sets of 
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ultrasound sequences used) to investigate how the choice of L affects the results. For the 
quantitative evaluation, we computed the contrast-to-noise ratio (CNR) values from B-
scans alone and LAND-localized frames with two region-of-interests (inclusion and 
background) in the phantom as a function of L. We estimated 95% confidence intervals 
(CIs), where the number of replicates were 13, 11, 9, 7, and 5 with L of 3, 5, 7, 9, and 11, 
respectively. In addition, to assess the practicality of the method, we evaluated the 
execution times in MATLAB by repeating processing with 100 trials to obtain average 
running times and their 95% CIs. The size of image was 1168 by 148 pixels. 
4.3 Results and Discussion 
 The top plot in Figure 23 shows a temporal profile of the linear ultrasound intensity 
measured on a pixel of the image containing LANDs. A corresponding movie is available 
online. The laser began pulsing at 0.4 s, and the pulse repetition interval of the laser was 
0.1 s (i.e., 10 Hz). Thus, the repeated blinking behavior of LANDs was observable in the 
profile every 0.1 s from 0.4 s onward. In the figure, the algorithm allocated LAND frames 
(with L = 3 and 5) and their corresponding ultrasound frames every 0.1s. When L = 3, the 
image processing method was able to produce LAND frames at 0.3 s since it used three 
sets of ultrasound sequences to localize the LANDs. Equally, when L = 5, this method 
could generate LAND frames as soon as five sets of ultrasound sequences were collected 
(i.e., the number of ultrasound frames containing five laser pulses). Then, it continued 
generating LAND frames every 0.1 s (i.e., every laser pulse). However, note that even if a 
LAND image was constructed at 0.3 s when L was three, it yielded no contrast since the 
laser pulsing had not commenced. In addition, before three laser pulses were fired, LAND 
frames were incomplete, and so the two LAND frames at 0.4 s and 0.5s were incomplete, 
transient images. Finally, from 0.6 s onward, the algorithm was able to create fully contrast-
enhanced LAND images. As a result, this method clearly localized the LAND-containing 
inclusion with L’s of both three and five. 
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Figure 23 – Ultrasound and LAND-localized images acquired in the phantom, 
containing a LAND-labeled inclusion as a function time.  Laser pulses start activating 
the LANDs at 0.4 s. Corresponding two sets of the LAND-localized frames are shown 
using L = 3 and L = 5. 



























































 Table 7 summarizes the CNR values of both unprocessed B-scans and LAND 
frames and the averaged processing times of LAND localization with various L (3 to 11). 
As L increased, the CNR improvement increased, but increasing L may also cause motion-
induced errors. Hence, maintaining as small an L as possible is desirable to avoid motion 
artifacts. The measured average processing times were all under 0.3 s per LAND frame 
without deliberate computational optimization. Depending on the choice of L, the frame 
rate of LAND-localized images ranged from 3 to 10 Hz, whereas the frame rate of B-scan 
was not compromised with this method (i.e., consistent at 288 Hz). These results indicate 
that our approach is practical and robust, and that it enables the real-time detection of 
LANDs necessary for future translational efforts. 
 
Figure 24 – Ultrasound and LAND-localized images of in vivo murine SLN as a 
function of time.  Laser pulses start activating the LANDs at 0.3 s. The LAND-
localized frames with L = 5 are presented. 
 In the in vivo study, we imaged the murine SLN with the same setup used in the in 
vitro study, and Figure 24 shows the results. Again, a corresponding movie is available 
online. In Figure 24, we overlaid B-scan ultrasound frames with LAND-localized frames 
(L = 5). A temporal profile on a selected pixel in the lymph node containing LANDs shows 
their blinking dynamics in response to laser activation. As expected, the more laser pulses 
used to trigger the LANDs, the better the method can localize the LANDs, which 
correspond to the location of the SLN. After irradiating the tissue with 5 laser pulses, the 
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SLN in Figure 24 was identified at 0.7 s with improved contrast over ultrasound alone (i.e., 
unprocessed B-scans obtained from 0.1 s to 0.4 s in Figure 24). 
 This study has demonstrated the potential of the developed LAND-localization 
method via phantom and in vivo results. However, the study has several limitations. First, 
we only showed the in vivo results obtained from a single mouse. Our continuing studies 
will include more animals to validate the method’s robustness. In addition, for the clinical 
translation of this technique, not only should the ability to process the data in real time and 
provide high contrast be considered, but also the biocompatibility of LANDs should be 
examined. For example, the Epolight 3072 dye used in this study has not been FDA-
approved, but our previous work has shown that the FDA-approved indocyanine green 
(ICG) dye was successfully loaded in perfluorocarbon nanodroplets, indicating that the 
LAND platform has high translational potential [133]. Lastly, we have not explicitly 
investigated the stability of LANDs (i.e., the number of cycles of vaporization and 
recondensation that LANDs can endure in response to pulsed laser irradiation). In these 
experiments, LANDs were imaged for at least five minutes, which equals to 3,000 cycles 
with our 10 Hz laser, suggesting their ability to reliably vaporize and recondense. In 
addition, our previous work has demonstrated that the vaporization of the LANDs depends 
on selected laser energy, indicating that the LANDs activated below their vaporization 
threshold do not vaporize and remain in the liquid state.[133] Thus, to utilize the blinking 
ability of LANDs, a proper choice of laser energy is required and a laser fluence of 50 
mJ/cm2 in this study allowed the LANDs to vaporize and recondense repeatedly. 
4.4 Conclusion 
 We have introduced a contrast-enhanced imaging method that relies on LANDs 
undergoing sustained and repeatable phase changes. The LANDs vaporize and recondense 
in response to pulsed laser irradiation; and given a constant laser PRF, they exhibit periodic 
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peaks in the temporal ultrasound signal. Based on this unique blinking phenomenon, we 
have built an imaging method that determines how regularly the temporal ultrasound 
fluctuates to create a LAND-localized frame. Through our in vitro study, we quantified a 
substantial improvement in CNR over conventional ultrasound achieved with low 
computational complexity. Furthermore, we successfully identified a murine SLN, 
illustrating the viability of our technique in a small animal model. These results 
demonstrate that our approach effectively and efficiently localized LANDs in real time, 
which is necessary for future work to translate this contrast agent platform to the clinic.  
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CHAPTER 5. SUPER-RESOLUTION IMAGING WITH 
ULTRAFAST ULTRASOUND IMAGING OF OPTICALLY 
TRIGGERED PERFLUOROHEXANE NANODROPLETS 
 The chapter was reproduced and reprinted with permission from H. Yoon, K. A. 
Hallam, and S. Y. Emelianov, “Super-resolution imaging with ultrafast ultrasound imaging 
of optically triggered perfluorohexane nanodroplets”, IEEE Transactions on Ultrasonics, 
Ferroelectronics, and Frequency Control, April, 2018. © 2018 IEEE. The reference can be 
found in [57]. 
 Super-resolution imaging with moving microbubbles has shown potential in 
identifying fine details of deep-lying vascular compartments. To image the extravascular 
targets, the current study has employed nanometer-sized, optically triggered 
perfluorohexane nanodroplets (PFHnDs). In response to pulsed laser irradiation, the 
PFHnDs repeatedly vaporize and stochastically recondense, resulting in random changes 
of ultrasound signals. Our previous study has shown that the stochastic recondensation of 
the PFHnDs can be used to isolate individual PFHnDs for super-resolution imaging. This 
study introduces an improved method for super-resolution imaging with ultrafast 
ultrasound imaging of PFHnDs. The previous method was based on subtraction of two 
consecutive ultrasound images to detect signals from recondensed, isolated droplets 
whereas our current method compounds respective multiple pre- and post-recondensation 
ultrafast ultrasound images prior to subtraction to improve the spatial resolution further. 
To evaluate the axial and lateral resolutions of our method, we repeatedly imaged a 
phantom containing PFHnDs using a programmable ultrasound system synchronized with 
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a pulsed laser system. As a result, our method improved the lateral and axial resolutions by 
54% and 68%, respectively, over the previous super-resolution imaging approach, 
indicating that it can be used for localizing extravascular molecular targets with superior 
accuracy. 
5.1 Introduction 
 Super-resolution ultrasound imaging techniques have shown unprecedented 
potential in mapping deep-lying microvasculature, which was virtually unattainable 
because of the fundamental tradeoff between spatial resolution and penetration depth in 
ultrasound imaging [134-136]. In ultrafast ultrasound localization microscopy (one of the 
most seminal super-resolution methods), the authors found that ultrafast imaging of gas 
microbubbles leads to the transient decorrelation of signals, enabling isolation of individual 
microbubble signals with the clinically relevant concentration of microbubbles [137]. 
Because the microbubble diameter is much smaller than the ultrasound wavelength, the 
signal reflected from each microbubble can be viewed as the point spread function (PSF) 
of the imaging system. Thus, the deconvolution of the individual microbubble signal allows 
for the detection of exact microbubble positions [138]. These super-resolved locations are 
accumulated over a few minutes with tens of thousands of images, resulting in the 
unsurpassed microvasculature map of the in vivo rat brain [135]. 
 Since then, more researchers have investigated pre-clinical and technical studies 
using super-resolution imaging techniques [139-146]. Lin et al. imaged in vivo tumor-
bearing rats to identify tumor angiogenesis and found that microvascular patterns of 
healthy and diseased rats are significantly different [139]. Foiret et al. reported that super-
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resolution imaging could successfully map the microvasculature of in vivo rat kidney in 
the presence of physiological motion [140]. Moving tissue, however, is a concern in super-
resolution imaging because it takes several minutes to collect a stack of images to create 
super-resolution maps. Thus, Hingot et al. introduced a phase correlation-based motion 
correction method and assessed the improvement in the quality of  super-resolution images 
[141]. More recently, the nonlocal means (NLM) filter and a graph-based particle tracking 
method were utilized for robust tracking of microbubbles [142]. Optimization of super-
resolution imaging has been investigated in several studies, showing the effect of various 
sizes and concentrations of microbubbles on the sensitivity of super-resolution imaging 
[143, 144]. Christensen-Jeffries et al. introduced a method that reduces axial localization 
errors of microbubbles by comparing various localization methods [145]. In addition, 3-D 
super-resolution imaging has been investigated using a pair of ultrasound transducers 
[146]. 
 The microbubble-based super-resolution imaging techniques can map 
microvasculature with a spatial resolution beyond the wave diffraction limit. However, 
because of their relatively large size (a few micrometers), microbubbles rarely extravasate 
from the vasculature, limiting the utility of super-resolution imaging [50]. As an alternative 
approach, super-resolution imaging with submicrometer-sized, optically triggered droplets 
was recently introduced [55]. Perfluorohexane nanodroplets were used in these studies 
because of their ability to vaporize and recondense in response to pulsed laser irradiation. 
The optically triggered PFHnD is one of many perfluorocarbon nanodroplet  species [49, 
52, 53, 132, 133], and not only can they be used for  super-resolution imaging, but also for 
contrast-enhanced imaging, by relying on the PFHnD’s unique ability to repeatedly 
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activate [56]. These PFHnDs can be synthesized at sub-micrometer sizes and are thus 
capable of reaching extravascular targets. The PFHnDs consist of a perfluorohexane core, 
an optical dye, and a fluorosurfactant shell [133]. In response to pulsed laser irradiation, 
the PFHnDs can be vaporized and become gaseous microbubbles that can be used for 
contrast-enhanced ultrasound images. Furthermore, because the boiling point of 
perfluorohexane (56°C) is higher than physiological body temperature, the PFHnDs can 
recondense to the native liquid state and can repeatedly undergo phase-transitions [133]. 
Luke et al. found that the recondensation process of PFHnDs is stochastic and thus at a 
given time during recondensation,  a sparse subset of PFHnDs can be obtained, allowing 
for isolation and localization of individual PFHnDs [55]. In their method, a stack of images 
was collected using conventional ultrasound imaging while PFHnDs were recondensing 
post-laser irradiation. Then, a signal from each PFHnD was isolated by taking a difference 
between consecutive images to detect randomly recondensed PFHnDs. 
 In this chapter, we propose a method for improving super-resolution imaging of 
PFHnDs using ultrafast ultrasound imaging and a temporal compounding approach. 
Specifically, before taking a difference of ultrasound sequences to detect a stochastic 
recondensation event, we combine multiple frames before and after droplet recondensation 
to suppress random background noise thus to improve the accuracy of super-resolution 
imaging. To demonstrate our approach, a tissue-mimicking phantom containing PFHnDs 
was used. 
5.2 Materials and Methods 
5.2.1 Super-Resolution Process with Optically-Triggered Perfluorohexane Nanodroplets 
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 Super-resolution imaging with PFHnDs relies on the random recondensation of 
PFHnDs. The vaporization and recondensation of PFHnDs are likely to be stochastic 
because they are a combined function of droplet size, local laser fluence, amount of dye 
captured, local temperature, local pressure, and local viscoelasticity [55, 79, 147]. To 
capture their random recondensation, high-frame-rate ultrasound imaging is required 
because PFHnDs typically recondense within several milliseconds [55, 147]. 
 
Figure 25 – An overall protocol for super-resolution ultrasound imaging with 
optically triggered perfluorohexane nanodroplets (PFHnDs). Thresholded images in 
the third row are binary images (green for zero and yellow for one) and the sparse 
isolated droplets, which do not have any other droplets located closely, are shown with 
white squares. 
 The overall protocol of super-resolution imaging with PFHnDs is illustrated in 
Figure 25. When the laser pulse irradiates the volume, the PFHnDs are immediately 
vaporized, producing high contrast ultrasound signals. Then, they begin stochastically 
condensing back to the original liquid state. As illustrated in Figure 25, the signals from 
vaporized PFHnDs appear in the second ultrasound image right after laser activation, and 
then these signals gradually disappear as a function of time because of the random 
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recondensation of PFHnDs. To detect a sparse subset of randomly recondensing droplets 
in each frame, differential ultrasound images are taken by subtracting adjacent ultrasound 
images (note that two terms differentiation and subtraction are used interchangeably in this 
chapter). In other words, post-laser ultrasound images are subtracted continuously, as 
shown in the second-row images, to produce a series of differential images. Then, 
thresholding is applied to reject high-frequency noise amplified by the differentiation 
process and to detect only the signals from recondensed PFHnDs. The thresholded images 
are binarized to find the location of droplet signals. From these binary images (images in 
the third row in Figure 25), the sparse isolated droplets, which do not have any other 
droplets located closely, are selected as shown with white-colored boxes in Figure 25. 
Subsequently, these PFHnD patches are fitted to a Gaussian approximation of the PSF of 
the imaging system, allowing for precise localization of PFHnD positions. Thus, each 
differential ultrasound image can produce a partial super-resolution map of a sparse subset 
of PFHnDs recondensed at that time. Finally, all super-resolved targets are combined to 
create a final super-resolution map. This entire process can be repeated in response to each 
pulsed-laser irradiation. 
5.2.2 Temporal Compounding Approach 
 To improve the reliability of super-resolution imaging and thus to further enhance 
the spatial resolution, this study uses ultrafast ultrasound imaging and introduces a 
temporal compounding approach that respectively averages multiple pre- and post-
recondensation images before taking a difference between consecutive ultrasound images. 
In an example illustrated in Figure 26, all PFHnDs in a particular region of interest vaporize 
immediately in response to laser illumination, but recondense at different times. Given that  
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Figure 26 – A diagram describing the temporal compounding approach. Here, the 
small dark blue circles present nanodroplets before activation and the large light blue 
circles vaporized microbubbles after activation. Yellow shaded region indicates the 
nanodroplets under laser illumination. 
the frame rate of ultrafast imaging is much higher than that of conventional beam-by-beam 
ultrasound imaging, in principle, several ultrafast frames can remain the same before 
recondensation (frames denoted by red outline in Figure 26). Similarly, several ultrafast 
frames can also remain the same after a specific recondensation event (frames denoted by 
blue outline). However, ultrasound images contain noise, which is amplified during the 
frame differentiation process, and therefore, the Gaussian approximation of the PSF of the 
system may not be reliable [148]. Thus, using temporal information obtained from ultrafast 
ultrasound imaging, pre- and post-recondensation frames are respectively compounded, 
and then the corresponding compounded frames with higher signal-to-noise ratio (SNR) 
are subtracted from each other to create a differential image. Here, the number of ultrafast 
frames used for compounding is an important parameter that determines the degree of 
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improvement. The rest of the super-resolution process follows the same protocol described 
previously [55]. Briefly, the differential images were thresholded to detect recondensed 
droplets, and Gaussian approximation was used determine the location of the detected 
droplets. 
 Similar to the previous approach, our method first detects recondensation events by 
differentiation and thresholding methods. In general, all detected, isolated droplets could 
recondense at different, random times and, therefore, would be captured in different 
frames. From every detected frame for each droplet, pre-recondensation and post-
recondensation images are compounded, respectively, according to our choice of the 
number of compounded frames. Two compounded images (i.e., one containing vaporized 
PFHnD signals and another containing recondensed background signals) are subtracted to 
obtain noise-reduced differential images as shown in Figure 26. In some cases, due to the 
random nature of droplet recondensation, the number of frames compounded pre-and post- 
recondensation could be different. A droplet recondensing "early" (when the number of 
desired compounded images is k and the recondensation event occurs prior to the kth frame) 
would limit the pre-recondensation frame compounding while the "late" recondensing 
droplet (when the recondensation event occurs within last k−1 frames) would limit post-
recondensation compounding. For example, if one droplet is deactivated in the third frame, 
then it would have at most only two pre-recondensation images to be compounded. This 
would not affect the post-recondensation compounding as the originally selected number 
of compounded frames (1-10) for analysis in post-recondensation would be used. As a 
result, a droplet that recondenses midway through acquisition best demonstrates the effect 
of temporal compounding to improve spatial resolution as it allows for the originally 
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selected number of compounded frames to be used pre- and post-recondensation. In 
addition, the number of frames for compounding would be further limited when pre- or 
post-recondensation patches for each droplet contain recondensation events from other 
closely located droplets, which are rejected by tracking the number of peaks in the patches. 
Thus, local peaks in each candidate patch are detected and when more than one occurs, that 
patch was not used. The size of the patch was determined by the ultrasound wavelength λ. 
In this study, the dimension of the patch was 3λ x 3λ (i.e., 0.96 mm x 0.96 mm). 
5.2.3 Experimental Set-Up 
 
Figure 27 – (a) An experimental set-up consisting of a linear array transducer with 
bifurcated optical fiber bundles and a fabricated polyacrylamide gel, and (b) a 
diagram representing the phantom containing PFHnDs. The red rectangle in the 
cubic phantom indicates an example cross-section as an imaging plane. 
 To verify the temporal compounding approach, we fabricated a tissue-mimicking 
phantom containing PFHnDs mixed in a polyacrylamide gel (Figure 27 (a)). It has been 
demonstrated that a polyacrylamide phantom has tissue-like acoustic properties such as 
density, sound speed, acoustic impedance, and attenuation; from the parameter published 
elsewhere [149], the acoustic attenuation coefficient was calculated to be 2.0 dB/cm at 9.6 
MHz (a center frequency used in this study). In addition, a polyacrylamide phantom has 
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desired optical properties as it is  transparent in the near-infrared region [150]. Although 
not performed in our study, the optical absorption and scattering properties of gel can be 
tuned using additives. 
 PFHnDs were prepared using 3 mL of deionized water, 0.3 mL of perfluorohexane 
(FluoroMed, L.P., Round Rock, TX, USA), 1 mL of Zonyl fluorosurfactant (1% v/v, 
Sigma-Aldrich, St. Louis, MO, USA), and 2 mg of near infrared absorbing dye (Epolight 
3072, Epolin, Inc., Newark, NJ, USA) with an optical absorption near 1064 nm 
wavelength. Droplets were formed by adding materials to a 7 mL scintillation vial, placing 
the vial in a water bath, and sonicating the mixture using a probe sonicator (Q500, QSonica 
LLC, Newtown, CT, USA) for 60 seconds at an amplitude of one. The resulting emulsion 
was washed in a mini-centrifuge (Mini-Spin, Eppendorf, Hamburg, Germany) at 400 rcf 
for 2 min. The supernatant was kept and the pellet discarded. Droplets were sized at 464 
nm ± 129 nm (Zetasizer Nano ZS, Malvern Instruments Ltd., Malvern, UK). From stock, 
the droplet concentration was ~108 nanodroplets/mL. 
 The volume of the phantom was 170 mL and consisted of 42.5 mL of 40% 
polyacrylamide solution (Thermo Fisher Scientific, Walthan, MA, USA), 1.7 mL of 10% 
ammonium persulfate solution (Sigma-Aldrich, St. Louis, MO, USA), 212.5 µL of 
TEMED (Sigma-Aldrich, St. Louis, MO, USA), and 127 mL of deionized water. The 
water, polyacrylamide solution, and ammonium persulfate were added to a Büchner flask 
and mixed using stir plate for about 10 minutes. Using a vacuum chamber, the volume was 
degassed. After degassing and prior to adding TEMED to solidify the polyacrylamide gel, 
17 µL of PFHnDs (1:10,000 dilution, ~104 nanodroplets/mL) from the stock were added 
to the solution. 
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 The approximate concentration of the droplets in the unit volume resulted in 10 
nanodroplets/mm3 (i.e., one nanodroplet per 100 μm3). Our study requires repeated 
tracking of individual droplets over multiple blinking events for resolution assessment. 
However, considering the ultrasound wavelength of 160 μm (9.6 MHz center frequency 
used in the study), the average spacing between nanodroplets would be not far greater than 
the resolution, which may not be appropriate in observing individual PFHnDs over the 
course of repeated vaporization and recondensation events. However, because the density 
of perfluorohexane (1.68 g/ml) is greater than water, many of them could settle down 
toward the bottom of the phantom while being solidified. Thus, we have fabricated the 
phantom with various concentrations and heuristically determined the concentration (i.e., 
104 nanodroplets/mL) to not only have the reasonable number of PFHnD signals, but to 
also have the appropriate PFHnDs sparsity for signal localization. 
 The fabricated phantom was imaged using a multi-wavelength photoacoustic and 
plane-wave ultrasound imaging system that combines a wavelength-tunable nanosecond 
pulsed laser (Phocus Mobile, Opotek Inc., Carlsbad, CA, USA) and a programmable 
ultrasound imaging system (Vantage 256TM, Verasonics Inc., Kirkland, WA, USA) 
equipped with a linear array transducer (L11-4v, Verasonics Inc., Kirkland, WA, USA) 
operating at 9.6 MHz center frequency [151]. In this study, a single optical wavelength of 
1064 nm was used; this wavelength is near the peak optical absorption of the dye-loaded 
PFHnD. Using nanosecond laser pulses delivered through the bifurcated optical fiber 
bundles placed on both sides of the ultrasound imaging transducer (Figure 27 (a)), the area 
of phantom underneath of the transducer was irradiated. The laser fluence measured from 
the output of the optical bundles was 47.5 mJ/cm2, satisfying the ANSI safety limit [114]. 
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Before and after the laser pulses, the irradiated area was imaged using ultrafast ultrasound 
to capture the temporal dynamics of the PFHnDs (Figure 27 (b)). A pulse-repetition-
frequency (PRF) of ultrafast ultrasound imaging was 9 kHz but, due to angular 
compounding of three plane-wave angles (−2°, 0°, +2°), the effective frame rate of 
ultrasound imaging was 3 kHz. For each laser pulse, 90 compounded ultrasound frames 
were collected. The Verasonics system beamformed all raw-format data and stored the 
resultant IQ data, which were processed off-line for super-resolution imaging. The PRF of 
laser pulses was 10 Hz thus the pulsed-laser irradiation and the ultrasound data acquisition 
were repeated every 100 ms. 
5.2.4 Lateral and Axial Resolution Assessment 
 
Figure 28 – Assessment of lateral and axial resolutions of super-resolution imaging. 
 To assess the effect of the temporal compounding in super-resolution imaging, 
lateral and axial resolutions as a function of the number of compounded frames were 
quantified using the method described elsewhere [55]. Specifically, we irradiated the 
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phantom with 50 laser pulses repeatedly and found the isolated droplets that blinked more 
than or equal to 30 times. Then, the distribution of at least 30 super-resolved positions from 
each droplet was fit to the Gaussian function both laterally and axially to obtain 
corresponding full width at half maximum (FWHM) in both directions as shown in Figure 
28. The FWHM in lateral and axial directions are referred to as FWHMlat and FWHMax, 
respectively. For the better statistical analysis, we repeated this process by imaging 7 
different cross-sections of the phantom. Using the droplets that blinked more than or equal 
to 30 times, found in these 7 imaging planes, we evaluated FWHMlat and FWHMax as a 
function of the number of temporally compounded frames. 
5.3 Results 
 
Figure 29 – Super-resolution imaging results with 7 imaging planes selected in the 
phantom. Columns represent different imaging planes from plane 1 to plane 7. The 
first and second row images represent pre- and post-laser activation ultrasound 
images, respectively. To employ the signals solely generated from the vaporized 
PFHnDs, differential images between pre- and post-laser ultrasound images were 
taken and presented in the third row. Super-resolution imaging was performed with 
50 laser pulses and the resulting super-resolved targets, accumulated over all laser 
pulses, are shown in the fourth row images. 
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 We imaged 7 cross-sections of the phantom where each cross-section (referred as 
Plane 1, Plane 2, … , Plane 7 in Figure 29) was exposed to 50 laser pulses accompanied 
with ultrafast ultrasound imaging. The results presented in Figure 29 show typical 
greyscale ultrasound images before and after laser pulses that led to optical activation of 
PFHnDs. In addition, differential ultrasound images for each cross-section are also shown 
in Figure 29. Finally, the resultant super-resolved targets were accumulated and displayed 
in the super-resolution maps shown in the last row in Figure 29. Here, 15 locations 
highlighted by the blue squares contain at least 30 and up to 50 super-resolved positions of 
the droplet while other super-resolved targets had less than 30 blinking events and were 
not used in further analysis. 
 
Figure 30 – Super-resolved positions of droplets (15 locations with droplets exhibiting 
at least 30 blinking events) as a function of the number of compounded frames (1, 2, 
4, and 8). 
 Using 15 locations of super-resolved droplets presented in Figure 29, we evaluated 
the effect of the temporal compounding approach and the corresponding resolution  
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Table 8 – Mean recondensation frames. 
Location Recondensation frame (mean ± STD) 
1 2.3 ± 0.8 
2 2.9 ± 0.9 
3 2.3 ± 0.5 
4 2.1 ± 0.2 
5 5.8 ± 3.9 
6 2.8 ± 0.7 
7 8.2 ± 4.1 
8 5.0 ± 2.3 
9 2.3 ± 0.4 
10 2.2 ± 0.4 
11 12.5 ± 4.6 
12 2.6 ± 0.5 
13 2.1 ± 0.5 
14  9.9 ± 2.0 
15 2.2 ± 0.4 
enhancement. Specifically, temporal compounding using one frame (i.e., no compounding) 
to 10 frames was applied, and the variations in the distribution of the super-resolved 
positions of each target were estimated. The results shown in Figure 30 indicate that the 
super-resolved positions tend to converge toward the center as the number of compounded 
frames increases. Indeed, temporal compounding reduces the variations in super-resolved 
targets and thus improves the reliability and the localization accuracy in super-resolution 
imaging. Table 8 lists the mean frame numbers and their standard deviations (STD), where 
the recondensation events occurred for all corresponding 15 droplets. As previously 
explained, the droplets are recondensed at random, and at different times. Therefore, even 
if our parameter of the number of compounded frames varies from 1 to 10, the number of 
pre- and post-recondensation frames to be compounded cannot be necessarily 1 to 10. For, 
 81 
example, for the droplet termed location 8, the mean recondensation frame was 5, meaning 
that its pre-recondensation images can be up to 4 frames on average. 
 
Figure 31 – FWHMlat and FWHMax assessment results as a function of the number of 
compounding frames. Blue lines represent the means of FWHMlat and FWHMax and 
black dotted lines represent corresponding 95% confidence intervals. 
 Furthermore, we quantified FWHMlat and FWHMax of the location of these 15 
droplets and evaluated their means and 95% confidence intervals. The results are presented 
in Figure 31 where blue lines represent the means of FWHMlat and FWHMax and black 
dotted lines represent their 95% confidence intervals. Here, the number of compounded 
frames equal to one corresponds to the previously introduced approach [55]. As can be 
seen in Figure 31, both FWHMlat and FWHMax decease as the number of compounded 
frames used increases. Compared to the previous approach where no compounding was 
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used, the temporal compounding improves the lateral and axial resolutions by up to 54% 
and 68%, respectively. 
5.4 Discussion 
 Our study revisited super-resolution ultrasound imaging of optically triggered 
PFHnDs introduced earlier [55]. Using ultrafast ultrasound imaging and temporal 
compounding, the localization of the targets was improved. Ultrafast ultrasound imaging 
captures an order of one to two times more temporal information on the transient, stochastic 
recondensation of the PFHnDs. Hence, before differentiating adjacent images to identify 
the recondensation event, the temporal compounding approach, which averages multiple 
pre- and post-recondensation images, could be applied to further improve the ability to 
localize the PFHnDs. Using the tissue-mimicking phantom containing PFHnDs, we have 
shown that our approach improves both lateral and axial resolutions by about a factor of 
two. Because frame averaging reduces electrical background noise, the Gaussian 
approximation of the PSF of the imaging system was more reliable, leading to improved 
spatial resolution. 
 To understand the theoretical limit of spatial resolution improvements in our 
approach, we have investigated how the random noise in the ultrasound image affects the 
Gaussian fitting process through the simulation. In super-resolution fluorescent imaging, it 
has been proven that the uncertainty of the Gaussian fitting (i.e., the position error of each 
measurement) is related to the standard deviation (STD) of the imaging system PSF, the 
number of photons, pixelation noise, and background electrical noise  [148]. Because the 
STD of the PSF and the pixilation noise would be fixed in the given system and the number 
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of photons is not applicable to ultrasound imaging, here we observed the changes in 
FWHM of the super-resolution imaging as a function of the background noise and as a 
function of the number of compounded frames. We modeled signals from pre-
recondensation PFHnDs as the PSF of the system and signals from post-recondensation 
PFHnDs as background. Then, we have added zero mean white Gaussian noise with STDs 
ranging from 0 to 0.25 with a step size of 0.05 to both pre- and post-recondensation images, 
resulting in the signal-to-noise ratios (SNRs) ranging from ∞ dB to 11.2 dB. The FWHM 
was measured as a function of the number of compounded frames on the subtracted images 
after temporal compounding. Figure 32 shows an exemplary comparison between 1 and 10 
compounded frames with the noise STD of 0.1. When the compounded frames were 10, 
the subtracted PFHnD signal was less noisy, leading to far reduced localization errors. 
 
Figure 32 – Simulation steps to evaluate the proposed approach with various 
electrical noise and the number of compounded frames. Here, the modeled PSF is 
added with noise with a STD of 0.1 to create noise-corrupted images. 1 and 10 
compounded frames are compared to present how they affect the distribution of 
localization positions. 
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 The results of the simulation are shown in Figure 33. Overall, as the number of 
compounded frames increases, FWHM decreases (i.e., spatial resolution improves) 
because the electrical background noise added reduces as the number of compounded 
frames increases. If SNR is ∞ dB (i.e., the noise STD is 0 or there was no noise), no 
localization error occurred, resulting in the FWHM of 0. However, as the SNR decreases, 
the FWHM becomes large up to about one pixel. As the number of compounded frames 
reaches 10, the improvement in the FWHM was almost five fold for the SNR of 11.2 dB. 
Overall results show that depending on the SNR of ultrasound images, the temporal 
compounding leads to gradual resolution improvement. 
 
Figure 33 – The estimated FWHM in terms of pixel as a function of the number of 
compounded frames with various SNRs. 
 In theory, the noise reduction by averaging signals is proportional to the square root 
of the number of the compounded frames. Thus, if we have the very large number of 
compounded frames, the effect of the noise should be negligible. However, our approach 
relies on the subtraction process between pre- and post-recondensation images, which 
amplifies the noise influence after averaging, limiting the decrease in FWHM. 
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Furthermore, as presented in Table 8, many droplets recondensed at relatively earlier 
frames (2 to 3). Therefore, our experimental results in Figure 31 show more limited 
improvements in resolution, compared to the simulation results in Figure 33. The droplet 
locations for 7, 11, and 14 had relatively larger mean recondensed frames, and thus, they 
resulted in the narrower distributions with respect to the number of compounded frames in 
Figure 30 compared to other droplets. As a result, the fundamental limit of the resolution 
improvement is dependent on noise of the system and the random recondensation timing 
of each droplet. 
 Although the frame compounding approach is simple and effective in resolution 
enhancement, combining multiple frames can cause physiological motion artifacts, which 
are critical in super-resolution [141]. However, even if 10 images (i.e., ideally 20 images 
for both pre- and post-recondensation images) are used for temporal compounding, it only 
requires imaging target to be stationary for 6.6 ms (the frame rate of 3 kHz in this study 
was used to compute the imaging time, i.e., 0.33 ms x 20 images). Fortunately, as can be 
seen in Figure 31, the enhancements in both lateral and axial resolutions is most noticeable 
for small number of frames. In other words, our approach only needs up to five frames to 
reach its almost full potential, which takes less than 3.3 ms (0.33 ms x 5 x 2 images). 
Furthermore, although we used the PRF of 9 kHz with three angles of plane waves, the 
PRF could be higher if the imaging depth permits (theoretically, for imaging of a 20-mm 
depth, the PRF can reach up to 38.5 kHz), which can further alleviate potential concerns in 
motion artifacts. 
 This study has not investigated the effect of the frame rate in super-resolution 
imaging. However, not only could the frame rate affect motion artifacts, but also it can 
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determine the overall imaging time or the number of isolatable nanodroplets per laser pulse. 
As discussed, the recondensation of the PFHnDs is a stochastic process. Therefore, if two 
closely-spaced droplets are recondensed at a slightly different time, then slower frame-rate 
imaging will identify them as recondensed at the same time thus not allowing for 
localization of each droplet. However, imaging with a faster frame rate should resolve them 
as two separable droplets. Thus, as the frame rate increases, an increased number of isolated 
droplets could be detected. Consequently, a higher concentration of PFHnDs can be used 
with higher frame rate imaging, which also will reduce the overall imaging time. Our future 
study will include the investigation of the effect of the frame rate in super-resolution 
imaging. 
 The laser-activated PFHnDs recondense randomly and thus at different times, 
which is the crucial finding that enables the super-resolution with nanodroplets. However, 
in our experiments, many droplets were recondensed in the first few ultrasound frames thus 
limiting the applicability of the temporal compounding approach. Thus, a method to make 
the recondensation of the droplets more stochastic and less transient should be studied in 
the future. If the stochastic behavior of the droplets could be manipulated, more super-
resolved targets could be imaged while the imaging session is shortened. For example, 
because the boiling point of a gas core affects recondensation dynamics, instead of pure 
perfluorohexane (boiling point: 56°C), a mixture of perfluorohexane and perfluoropentane 
(boiling point: 29°C) could be used to extend the recondensation time [147]. In addition, 
to make droplet recondensation more random, a polydisperse distribution of droplets can 
be used because the size of droplets also affects the recondensation time. 
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 The penetration depth of light is typically more limited than that of an acoustic 
wave. Therefore, to reach full potential of the optically triggered PFHnD-based super-
resolution imaging, a thorough investigation of the activated depth of the PFHnDs is 
necessary. Our previous work using perfluoropentane nanodroplets has shown that these 
droplets can be vaporized at further than a 3-cm depth  in turbid media [53]. The PFHnDs 
may have a slightly shallower imaging depth because they could require higher optical 
fluence to be activated due to the higher boiling point. Therefore, clinical applications using 
the PFHnDs could be restricted. However, it has been shown that negative pressure of 
externally applied acoustic field could be used together with laser pulses to increase the 
activation efficiency of droplets [152]. 
 Unlike super-resolution imaging based on micrometer-sized contrast agents, we 
have used submicrometer-sized nanodroplets capable of extravasating from the vascular 
compartment, which may expand the utility of super-resolution imaging. Currently 
available imaging methods struggle to characterize in vivo tumors at the molecular and 
cellular level. Understanding the molecular composition of a tumor is crucial in treatment 
planning and outcome because tumor cells are genetically heterogeneous [4, 5]. Super-
resolution imaging with molecularly targeted PFHnDs could be a solution in identifying 
the tumor microenvironment, enabling the effective personalized treatment. 
5.5 Conclusion 
 We have introduced a method for improving super-resolution imaging with 
ultrafast ultrasound imaging of optically triggered PFHnDs. The frame compounding 
approach was suggested and verified with the phantom containing PFHnDs. Quantitative 
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assessment of the method has shown that lateral and axial resolutions can be reduced by 
54% and 68%, respectively, over the previous approach, indicating that it can be used for 
localizing extravascular molecular targets with improved accuracy. 
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CHAPTER 6. COMBINED MULTI-WAVELENGTH 
PHOTOACOUSTIC AND PLANE-WAVE ULTRASOUND 
IMAGING FOR PROBING DYNAMIC PHASE-CHANGE 
CONTRAST AGENTS 
 The chapter was reproduced and reprinted with permission from H. Yoon, and S. 
Y. Emelianov, “Combined multi-wavelength photoacoustic and plane-wave ultrasound 
imaging for probing dynamic phase-change contrast agents”, IEEE Transactions on 
Biomedical Engineering, June, 2018. © 2018 IEEE. The reference can be found in [153]. 
 The purpose of this study was to introduce combined multi-wavelength 
photoacoustic (PA) and plane-wave ultrasound (US) imaging referred to as mwPA/pwUS 
imaging capable of probing the rapid dynamic behavior of optically activated phase-change 
contrast agents. A dedicated mwPA/pwUS imaging sequence was developed based on a 
programmable US system synchronized with a tunable laser to irradiate tissue with laser 
pulses at desired optical wavelengths and to acquire post-laser-pulse PA images followed 
by ultrafast plane-wave US images. To evaluate the mwPA/pwUS imaging, a capillary 
filled with optically responsive perfluorohexane nanodroplets (PFHnDs) containing a dye 
with the peak absorption at 760 nm was imaged with optical wavelengths ranging from 700 
nm to 940 nm. The differences between post-laser ultrafast US images (i.e., differential US 
(ΔUS)) were taken to visualize the recondensation dynamics of PFHnDs at each 
wavelength. The PA images of PFHnDs showed higher contrast near 760 nm, 
corresponding to the peak absorption of the dye encapsulated in the PFHnDs. Moreover, 
the ΔUS signals immediately after 760 nm pulsed-laser irradiation were also high due to 
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the increased US contrast associated with vaporized PFHnDs. The mwPA/pwUS imaging 
allowed for the US-based optical spectroscopic characterization of PFHnDs and their 
dynamics. The introduced mwPA/pwUS imaging sequence can be used in various clinical 
applications where both spectroscopic PA imaging of endogenous and/or exogenous 
chromophores and ultrafast US imaging of phase-change nanodroplets are desired. 
6.1 Introduction 
 Phase-change ultrasound contrast agents such as perfluorocarbon nanodroplets 
have demonstrated promising potential in various diagnostic ultrasound and therapeutic 
applications [48, 51]. Unlike traditional microbubbles (usually 1−5 µm diameter), phase-
change contrast agents can be synthesized at sub-micrometer sizes, which allows them to 
extravasate from the intra-vascular space [47, 154]. In addition, because of their relative 
stability, these phase-change contrast agents can circulate longer than microbubbles [45]. 
Once administered, they can be vaporized by an acoustic trigger to undergo a liquid-to-gas 
phase transition, providing on-demand high contrast ultrasound [131, 155]. 
 Optically triggered nanodroplets (nDs) are a new class of phase-change contrast 
agents [49]. These nanodroplets contain optical absorbers (e.g., dyes or nanoparticles) that 
can be used to vaporize perfluorocarbon nDs in response to pulsed-laser irradiation [49, 
52, 129, 130]. Perfluorohexane nanodroplets (PFHnDs) with the boiling point (56°C), 
higher than the physiological body temperature (37°C), recondense after vaporization. 
Importantly, this vaporization-condensation process is repeatable, which offers repeated 
high-contrast photoacoustic (PA) and ultrasound (US) signals. Here, PA signals are 
generated from both the vaporization of PFHnDs and the thermal expansion of dye within 
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PFHnDs. US signals are increased due to an acoustic backscattering from the transient 
microbubbles formed right after vaporization of PFHnDs. 
 The recondensation of PFHnDs is a function of many factors including core type, 
droplet size, photoabsorber type, local optical fluence, local temperature, local acoustic 
pressure, and local viscoelasticity [55, 79, 147]. The droplet recondensation is, therefore, 
transient and stochastic in general. Previously, the gas-to-liquid transition of PFHnDs 
captured via ultrasound imaging was demonstrated in several applications including super-
resolution imaging of the vasculature and contrast-enhanced imaging of the mouse lymph 
node [55, 56, 133].  However, it has been experimentally shown that the recondensation of 
the PFHnDs typically takes just a few milliseconds although it could vary from a few 
microseconds to tens of milliseconds [55, 147]. Therefore, high-frame-rate ultrasound 
imaging is required to capture the gaseous state of vaporized PFHnDs prior to 
recondensation. 
 Previously, PFHnDs were imaged using a preclinical US and PA imaging system 
(Vevo 2100, FUJIFILM VisualSonics, Inc., Toronto, ON, Canada), where laser 
illumination was not synchronized with US imaging; this was done to achieve high-frame-
rate US imaging during laser activation of the PFHnDs [55, 56, 133]. Consequently, no 
corresponding PA images were obtained due to technical limitations of the US/PA system, 
operating at 20 Hz or slower. Thus, high frame rate US imaging synchronized with PA 
imaging is desired to fully exploit the benefits of optically triggered contrast agents such 
as PFHnDs. 
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 Introducing a tunable laser to trigger nDs containing photoabsorbers with distinct 
optical absorption peaks allows for selective activation of nDs, enabling multiplexed 
imaging of molecularly targeted nDs. A previous study has shown that a subset of 
perfluoropentane nanodroplets (PFPnDs) can be selectively activated at the wavelength 
corresponding to the particular optical dye inside the PFPnDs, whereas the other PFPnDs 
containing the dye with different peak absorption were not activated [156]. Due to the low 
boiling point of perfluoropentane (29°C), the PFPnDs vaporize but do not recondense. 
Therefore, low-frame-rate US and spectroscopic PA (sPA) imaging were used. However, 
to extend this method to image PFHnDs, high-frame-rate US with sPA imaging is needed. 
In addition, sPA imaging not only enables the selective activation and imaging of nDs, but 
also allows for the quantification of chromophores’ concentrations. 
 The goal of this study was to design, implement, and test an imaging sequence 
capable of acquiring spectroscopic PA (sPA) images followed by ultrafast ultrasound 
images. This imaging sequence, referred to as multi-wavelength PA and plane-wave US 
(mwPA/pwUS) imaging, can capture the dynamic behavior of PFHnDs and can be used in 
various applications including super-resolution imaging, contrast-enhanced imaging, and 
molecular multiplex imaging. 
6.2 Multi-Wavelength PA and Plane-Wave US imaging 
6.2.1 System Configuration 
 To implement mwPA/pwUS imaging, a programmable ultrasound system (Vantage 
256TM, Verasonics Inc., Kirkland, WA, USA) and a tunable pulsed laser (Phocus Mobile, 
Opotek Inc., Carlsbad, CA, USA) were interfaced and synchronized with a host controller 
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(Figure 34). Bifurcated optical fiber bundles placed at two sides of a linear array transducer 
were connected to the laser system to irradiate the imaging volume with laser pulses at 
1,064 nm (Nd:YAG primary wavelength) or 690 nm – 950 nm (Nd:YAG laser pumped 
OPO system). To tune the laser wavelength, the laser was controlled by the host controller 
using dedicated dynamic-link libraries. Using the MATLAB (MathWorks, Natick, MA, 
USA), customized imaging routines were developed to sweep the optical wavelength and 
to acquire post-laser-pulse PA and ultrafast US images. 
 
Figure 34 – (a) Block diagram and (b) photograph of the mwPA/pwUS system 
containing an ultrasound imager, a laser system, a host controller, and an integrated 
imaging probe consisting of an ultrasound transducer and optical fiber bundles. 
6.2.2 Imaging Sequence 
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Figure 35 – (a) Real-time US and real-time US/PA imaging mode. (b) mwPA/pwUS 
imaging mode, where gray lines present ultrafast ultrasound frames acquired as a 
function of time, and red, yellow, and green lines present multi-wavelength laser 
pulses. Light blue lines indicate photoacoustic frames. (c) A detailed view of an 
imaging segment of the overall mwPA/pwUS imaging. 
 The overall imaging sequence consisted of real-time US/PA imaging as a default 
mode (Figure 35 (a)) and mwPA/pwUS imaging as an acquisition mode (Figure 35 (b)). 
The default real-time imaging was used to identify imaging targets before switching to the 
acquisition mode. In the mwPA/pwUS imaging, laser pulses with pre-selected wavelengths 
(i.e., λ1, λ2, … , λN) were used for two purposes: to activate PFHnDs, and/or to obtain sPA 
images. After irradiating the tissue with a laser pulse at a desired wavelength and obtaining 
a corresponding PA image, ultrafast US imaging captured the temporal dynamics of 
PFHnDs. 
 The imaging sequence started with irradiation of a laser pulse tuned to a particular 
wavelength, followed by PA and US imaging. Each segment of an imaging sequence, 
outlined using a blue dotted rectangular box (Figure 35 (b) and (c)), consisted of several 
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modules including wavelength tuning, Q-Switch delay, PA image acquisition, ultrafast US 
image acquisition, and data transfer (Figure 35 (c)). For TTUNE, the laser system was tuned 
to produce a desired optical wavelength. Then, the ultrasound system waited for TWAIT for 
a “flashlamp OUT” trigger signal from the laser system. The flashlamp signal is generally 
periodic, and in the case of our laser system, it was repeated every 0.1 sec (10 Hz). Once 
triggered, the ultrasound system sent out a “trigger OUT” signal after a pre-determined Q-
Switch delay (TQS_DELAY) to irradiate a laser light. After the “Q-Switch IN” signal from the 
Verasonics system activated laser pulse generation, PA acquisition began immediately and 
continued for half of a pre-defined US pulse-repetition interval (PRI) (i.e., TPRI/2). Thus, 
the Verasonics system controlled the Q-Switch delay signal, determining the laser fluence. 
Then, ultrafast US images were acquired based on the user-defined number of plane-wave 
angles and frames. Each imaging segment per laser pulse concluded with transfer of 
captured data (TTRANSFER). 
 For mwPA/pwUS imaging, the single-wavelength PA and ultrafast imaging was 
repeated for each optical wavelength, i.e., until the last optical wavelength (λN) was reached 
(Figure 35 (b)). 
6.2.3 PFHnD Synthesis and Phantom Experiments 
 The PFHnDs were synthesized by sonication-based methods, described in detail 
elsewhere [133]. The resulting PFHnDs consisted of a fluorosurfactant (Zonyl FSO, 
Sigma-Aldrich, St. Louis, MO, USA) shell with a liquid perfluorohexane (FluoroMed, 
L.P., Round Rock, TX, USA) and an optical dye (Epolight 9151, Epolin Inc., Newark, NJ, 
USA). The optical absorption peak of the dye was around 760 nm. 
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Figure 36 – (a) Experimental setup for imaging PFHnDs and (b) an example B-scan 
ultrasound image of the cross-section of the tube. 
 To test the developed system, a phantom containing a small capillary (inner and 
outer diameters are 1.6 mm and 2.9 mm, respectively), filled with PFHnDs and positioned 
horizontally in a plastic cuvette, was prepared (Figure 36 (a)). The integrated imaging 
probe was positioned above the tube phantom, and the phantom was imaged such that the 
capillary tube was orthogonal to the imaging plane (Figure 36 (b)). 
 A linear array transducer (LZ201, FUJIFILM VisualSonics Inc., Toronto, ON, 
Canada) integrated with optical fibers was used. This transducer was connected to the 
ultrasound system via an adapter (UTA 360, Verasonics Inc., Kirkland, WA, USA). A 
single angle (0°) of a plane wave with a center frequency of 15.6 MHz (i.e., the wavelength 
was 98.6 µm) at a pulse repetition frequency (PRF) of 3 kHz was used for ultrafast US 
imaging. For an imaging depth of 20 mm, the PRF can be up to 38.5 kHz. However, to 
avoid reverberation artifacts, a PRF of 3 kHz was used in our study. Because angular 
compounding was not used, the effective frame rate was the same as the PRF. An optical 
wavelength range from 700 nm to 940 nm with a 30-nm step was used. At each wavelength, 
a single PA image and 30 US images were collected and displayed using a logarithmic 
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scale with a dynamic range of 40 dB. To allow for better visualization of the recondensation 
of PFHnDs, the static signals were rejected by taking a difference between adjacent US 
frames. 
6.3 Results and Discussion 
 
Figure 37 – Photoacoustic and differential US (ΔUS) images of a capillary tube 
containing PFHnDs. The images were obtained at different optical wavelengths 
ranging from 700 nm to 940 nm. Each ΔUS image was generated by taking a 
difference between first two post-laser ultrasound frames. 
 PA and differential US (ΔUS) images obtained from the tube containing PFHnDs 
are shown in Figure 37. Because PFHnDs had the dye with a peak optical absorption at 
760 nm, the PA signals are stronger near 760 nm than those at other wavelengths. Starting 
from 790 nm, the magnitude of PA signals decreases as wavelength increases. The 
corresponding ΔUS images obtained from the first and second US images are presented as 
a function of wavelength (Figure 37). Given that the ΔUS images represent differences 
between consecutive images right after the laser activation of PFHnDs, the higher signals 
in ΔUS images indicate that PFHnDs were successfully vaporized and recondensed. 
Similar to the PA images, ΔUS signals were high at around 760 nm. The ΔUS signals at 
optical wavelengths of 880 nm, 910 nm, and 940 nm were very weak, indicating that at 
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these wavelengths the PFHnDs were not vaporized and recondensed, thus producing no 
change in ΔUS images. 
 
Figure 38 – Mean intensity of PA and ΔUS images inside the tube as a function of 
optical wavelength and time after each laser pulse. Orange ΔUS line was obtained 
with US images under no laser irradiation. 
 Mean intensity of PA (red lines) and ΔUS (green to blue lines) signals inside the 
tube as a function of both optical wavelength and time is plotted in Figure 38. Both PA and 
ΔUS signals are clearly wavelength dependent. Although the peak absorption of the dye 
was at 760 nm, the PA signals were strong within a range from 700 nm to 820 nm due to 
spectral shift and/or broadening of the absorption of the dye encapsulated in the droplet 
shell. The PA signals started to decay as wavelength increases beyond 850 nm. The ΔUS 
signals at higher wavelengths (> 880 nm) do not change significantly over time, which 
indicates that if the laser wavelength is far from the peak absorption, no vaporization of 
PFHnDs occurs, and, therefore, ΔUS signals remain low and almost the same as the ΔUS 
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signals under no laser irradiation (orange line in Figure 38). However, for the ΔUS signals 
at lower wavelengths (< 850 nm), the large amplitude of ΔUS right after laser pulses 
demonstrates the occurrence of the PFHnD vaporization. As the PFHnDs recondensed over 
time, the ΔUS signals accordingly reduced. 
 In the current study, we observed the vaporization and the recondensation of the 
PFHnDs repeatedly at the same location. In our previous study, we have shown that the 
PFHnDs, can repeatedly vaporize and recondense for more than a few thousand times [56]. 
In the future studies, we will employ the developed imaging sequence to characterize the 
dynamics of PFHnDs quantitatively. 
 We have demonstrated the feasibility of mwPA/pwUS imaging using PFHnDs. 
Although an exogenous agent was used in our study, use of mwPA/pwUS imaging is not 
limited to contrast-enhanced ultrasound imaging and could be used in various clinical 
applications. For example, our mwPA/pwUS imaging should be able to simultaneously 
assess the oxygen saturation level for tumor characterization based on the sPA imaging 
mode and visualize the dynamics of PFHnDs for tumor detection based on the ultrafast 
imaging mode [56, 157]. Thus, our approach can be potentially used for both detection and 
characterization of cancer. 
6.4 Conclusion 
 We have introduced combined mwPA/pwUS imaging as a tool to probe dynamic 
phase-change contrast agents. The ability of mwPA/pwUS imaging was demonstrated in 
the phantom study where a capillary tube containing PFHnDs was visualized and analyzed. 
We have shown that both acoustic and optical features of the PFHnD dynamic behavior 
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were captured as a function of time and optical wavelength. A poteintial future study will 
include testing and optimization of the developed imaging method in in vivo studies.  
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CHAPTER 7. DESIGN AND DEMONSTRATION OF A 
CONFIGURABLE IMAGING PLATFORM FOR COMBINED 
LASER, ULTRASOUND, AND ELASTICITY IMAGING 
 This chapter introduces a configurable combined laser, ultrasound, and elasticity 
(CLUE) imaging platform. The CLUE platform enables imaging sequences capable of 
uniquely providing quantitative acoustic, optical, and mechanical contrast for 
comprehensive diagnosis and monitoring of complex diseases, such as cancer. The CLUE 
imaging platform was developed on a Verasonics ultrasound scanner integrated with a 
pulsed laser, and it was designed to be scalable and modular to allow researchers to create 
their own specific imaging sequences efficiently. The CLUE imaging platform and 
sequence were demonstrated in a tissue-mimicking phantom containing a stiff inclusion 
labeled with optically-activated nanodroplets and in an ex vivo mouse spleen. We have 
shown that CLUE imaging can simultaneously capture multi-functional imaging signals 
providing quantitative information on tissue. 
7.1 Introduction 
 In the previous chapter, we have introduced combined multi-wavelength 
photoacoustic and plane-wave ultrasound (mwPA/pwUS) imaging that can trigger laser 
pulses with multiple optical wavelengths to support sPA imaging and activate the PFHnD; 
it allows for observation of transient PFHnD dynamics activated at various optical 
wavelengths by ultrafast US imaging [158]. The mwPA/pwUS imaging has shown its 
promising ability to capture acoustic and optical contrast of PFHnDs as a function of both 
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time and optical wavelength, but it cannot measure the mechanical properties of tissue. To 
address this issue, there were a few attempts combining ultrasound, photoacoustic, and 
elasticity imaging. Emelianov et al. combined strain imaging-based elasticity imaging and 
single-wavelength photoacoustic imaging [159]. However, strain imaging could not offer 
quantitative mechanical properties and single-wavelength PA imaging does not quantify 
the concentration of chromophores. More recently, Nguyen et al. replaced strain imaging 
by quantitative SWEI and added thermal strain imaging, quantifying lipid-based tissue 
composition [160]. However, their PA imaging remains qualitative, and their system does 
not support mwPA/pwUS imaging. 
 This chapter introduces a configurable, module-based imaging platform, referred 
to as the combined laser, ultrasound, and elasticity (CLUE) imaging platform. The CLUE 
imaging platform is capable of supporting various imaging sequences for general 
researchers in this field to explore a wide array of clinical applications. In the design of the 
imaging platform, we define each imaging function as a “module,” and we allow users to 
allocate these imaging modules arbitrarily to design their own custom imaging sequences 
according to their specific needs. Currently, we introduce 14 imaging modules including 
pulsed-laser excitation, ultrafast US acquisition, and ARF application. These imaging 
modules can be freely placed as a series of imaging functions when designing an imaging 
sequence. We have developed the CLUE imaging platform using a specific ultrasound 
research scanner and laser system, but our design philosophy can be adapted to other 
hardware. Our CLUE imaging platform and relevant graphical user interface (GUI) scripts 
are shared in a script repository in the Verasonics Community 
(http://verasonicscommunity.com). Furthermore, this chapter introduces a combined 
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imaging sequence referred to as a CLUE imaging sequence that acquires all ultrasound-
based quantitative mechanical and functional information on tissue using SWEI and PA 
and ultrafast US imaging with laser-activated PFHnDs. Because the CLUE imaging 
sequence can assess multiple quantitative aspects of tissue simultaneously, it potentially 
can be used to comprehensively characterize the prognosis and treatment response of 
diseases, such as cancer. 
 In this chapter, we first introduce a system configuration consisting of an ultrasound 
system and a laser, and then we explain design details of the developed CLUE imaging 
platform. Next, we present a representative CLUE imaging sequence, designed on the 
CLUE imaging platform. To demonstrate this imaging sequence on the CLUE imaging 
platform, experimental methods for phantom and ex vivo mouse spleen imaging studies are 
described. Subsequent imaging results and discussion follow. 
7.2 Design of Configurable Imaging Platform 
7.2.1 A Set-Up for Laser and Ultrasound Systems 
 Our configurable CLUE imaging platform was developed on a programmable 
ultrasound research scanner (Vantage 256TM; Verasonics, Inc., Kirkland, WA, USA) 
integrated with a tunable pulsed laser (Phocus Mobile; Opotek Inc., Carlsbad, CA, USA) 
as illustrated in Figure 39. Note that although the Phocus Mobile laser was used, other laser 
systems are not excluded, as typical laser systems have a similar communication protocol. 
In addition, the CLUE imaging platform was designed on the Verasonics scanner, but the 
same design approach could be applied to other ultrasound imaging systems.  
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Figure 39 – Block diagram of an overall imaging set-up with integrated ultrasound 
and laser systems. 
 In our setup, the laser and the Verasonics system communicate in the following 
order: (1) A periodic Flashlamp OUT signal from the laser triggers the Verasonics system 
through Trig IN1, and (2) when triggered, the Verasonics system sends a Trig OUT signal 
to the laser through a function generator to fire an actual laser pulse after a pre-determined 
Q-Switch delay. Here, a Q-Switch delay is a delay time between the Flashlamp OUT signal 
and the Q-Switch IN signal, and it determines the energy of a laser pulse. In general, a 
longer Q-Switch delay makes the output energy of the laser weaker.  When delivering the 
Trig OUT signal from the Verasonics system to the Q-Switch IN of the laser, the function 
generator is used to invert the phase and to extend the duration of the Trig OUT signal in 
order to satisfy the input requirements of the Phocus laser. The same approach can also be 
found from our previous study [158]. Additionally, a laser energy meter (Pulsar-2; Ophir 
Optronics Solutions, Inc., Jerusalem, Israel) placed inside the laser was used to measure 
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and collect the energy of irradiated laser pulses. Lastly, in the case that the time delay 
between the Trig OUT signal and the actual laser pulse is not negligible, which may delay 
the generation of PA signals, a photo-detector can be incorporated to synchronize PA 
imaging. The photo-detector can output a trigger once it senses pulsed-laser irradiation. 
The trigger can also potentially be used with the second trigger input (Trig IN2) of the 
Verasonics system.  
7.2.2 Module-based Configurable Imaging Platform 
 The overall process of imaging sequence design and execution using our imaging 
platform, referred to as the “CLUE imaging platform,” is illustrated in Figure 40. The 14 
imaging modules listed in Table 9 are shown on top of Figure 40. The crux of the CLUE 
imaging platform is that it allows users to design any customized imaging sequence by 
flexible, serial allocation of “imaging modules” and selection of relevant imaging 
parameters according to their specific need, as shown in Figure 40. Based on the designed 
imaging sequence, the CLUE imaging platform scalably generates all relevant Verasonics 
objects that are required to run the system. 
Table 9 – Imaging modules used in the CLUE imaging platform. 
Module name Description 
UF Ultrafast imaging 
UF-PI Ultrafast pulse inversion imaging 
UF-INTL Ultrafast interleaved imaging 
UF-PI-INTL Ultrafast pulse inversion interleaved imaging 
LL Line-by-line imaging 
LL-PI Line-by-line pulse inversion imaging 
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LL-INTL Line-by-line interleaved imaging 
LL-PI-INTL Line-by-line pulse inversion interleaved imaging 
PA Photoacoustic imaging 
ExtLaser Pulsed-laser excitation 
IntARF ARF excitation with an imaging transducer 
ExtARF ARF excitation with an external transducer 
Doppler Color/power Doppler imaging 
Idle Idle time delay (no operation) 
 The imaging modules consist of 14 fundamental building blocks of the imaging 
sequence, as defined in Table 9. UF represents ultrafast ultrasound imaging, which acquires 
a full two-dimensional image with plane-wave compounding, and LL line-by-line 
ultrasound imaging that sequentially acquires each scanline per transmit-receive event with 
a focused beam [73]. The UF and LL modules can be extended with either PI or INTL or 
both. PI supports pulse-inversion-based harmonic imaging and INTL enables multiple 
acquisition with different transmit offset times to increase the effective sampling rate for 
high-frequency ultrasound imaging. For example, since the maximum sampling rate of the 
Verasonics system is 62.5 MHz, two interleaved acquisitions can make the effective 
sample rate 125 MHz, supporting an effectively doubled center frequency. The PA module 
only receives the signals, and thus, it usually necessitates a preceding ExtLaser module, 
which irradiates a laser pulse to generate the photoacoustic signals. Nevertheless, the PA 
and ExtLaser modules are designed to be independent like other modules. Hence, either 
one of them can be used independently according to the study purpose. The IntARF and 
ExtARF modules are to apply an ARF to create shear waves for SWEI. Here, for ARF 
excitation, the IntARF module uses an imaging transducer connected to the Verasonics 
system, but the ExtARF module triggers an external transducer. The Doppler module 
acquires both color and power Doppler images for flow quantification. The Idle module 
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creates an idle wait step for a user-specified time duration to control the acquisition timings 
between other modules. These fundamental modules can be used to create various imaging 
sequences. For example, a simple US/PA imaging sequence can be designed with a series 
of the UF (or LL), ExtLaser, and PA modules. 
 
Figure 40 – Design and execution process of an imaging sequence using the CLUE 
imaging platform. All imaging modules here are uniquely color-coded for better 
visualization of them for the rest of this chapter. 
 The CLUE imaging platform offers three default real-time imaging methods: US, 
US/PA, and US/Doppler imaging modes. A user can switch to any of these three modes in 
a Verasonics GUI. A button was created on the GUI to execute the user-designed custom 
imaging sequence. Real-time imaging will be paused when the data acquisition is in 
process. Once data is acquired and saved for offline processing, real-time imaging will 
resume. In Figure 40, a representative imaging sequence is shown. First, a sham laser pulse 
is placed at the beginning for synchronization of the US system and the laser. Because the 
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timing of pulsed-laser irradiation is determined by periodic Flashlamp OUT triggers of the 
laser, the sham laser pulse allows the sequence to expect an irradiated timing of the next 
actual laser pulse, enabling acquisition of US images exactly prior to the actual laser 
excitation. Specifically, the pulse-repetition frequency (PRF) of the Flashlamp OUT signal 
is constant at 10 Hz in the Phocus laser (i.e., pulse-repetition interval (PRI) of 100 ms). 
Thus, the Idle module with an appropriate duration can be inserted right after the irradiation 
of the sham laser pulse specified by the ExtLaser module. For example, if pre-laser US 
imaging is to acquire 50 frames at 10 kHz, it will take 5 ms for data acquisition. Thus, 95 
ms (= 100 ms (laser PRI) – 5 ms (pre-laser US acquisition)) of the Idle module duration is 
needed to enable the pre-laser US acquisition right before the actual laser pulse. Following 
the laser irradiation, corresponding PA and post-laser US images are captured in the 
imaging sequence. Then, two SWEI processes are executed, where each process consists 
of two modules: an IntARF module for ARF application and a subsequent UF module for 
shear wave observation. Here, two IntARF modules in two SWEI processes apply the ARF 
beams at different lateral positions to cover a complete view of SWEI mapping. The Idle 
module between two SWEI acquisitions is to ensure the safety limits on acoustic intensities 
outlined by the Food and Drug Administration [80].  
7.2.3 Interface of CLUE Imaging Platform 
 Verasonics systems are one of the most widely used research ultrasound scanners 
in a diverse array of applications: from nondestructive evaluation (NDE) to clinical 
diagnosis (http://verasonics.com/scientific-references/). A user can design and use their 
imaging sequence by defining Verasonics objects in the MATLAB (MathWorks, Natick, 
MA) environment. The Verasonics objects are classified in two groups: global system 
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objects and sequence objects. The global system objects (Resource, Trans, and PData) 
define system specifications, medium properties, and transducer characteristics. The 
sequence objects (TW, TX, TPC, Receive, Recon, ReconInfo, Process, Event, and 
SeqControl) determine a sequence of imaging, image reconstruction, and image display. 
Thus, as shown in the left part of Figure 41, a user is required to define all Verasonics 
objects to run their script on the system (various example scripts and a detailed user manual 
are provided with the system). 
 
Figure 41 – A diagram showing the role of the CLUE imaging platform in interfacing 
users and Verasonics software and hardware. 
 The CLUE imaging platform is a module-based configurable imaging platform, 
providing non-advanced users a shortcut to sophisticated imaging sequences. As shown in 
the right part of Figure 41, the CLUE imaging platform interfaces Verasonics software and 
hardware on behalf of a user, and thus, one only needs to define their imaging sequence by 
allocating the imaging modules listed in Table 9. All objects required in the Verasonics 
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programming script are generated by our platform automatically. Once the imaging 
sequence is defined, relevant parameters per imaging module can be set in the script or 
through a custom-made GUI. In Figure 42, all imaging modules used in the imaging 
sequence appear as color-coded buttons. Each module or button can be chosen to adjust 
relevant parameters listed in the table on the right panel. Then, the CLUE imaging platform 
creates the corresponding Verasonics objects scalably according to the designed imaging 
modules with the determined parameters. 
 
Figure 42 – A graphical user interface for setting imaging parameters of all imaging 
module. 
7.3 Experimental Methods and Materials 
7.3.1 Combined Laser, Ultrasound, and Elasticity (CLUE) Imaging 
 To demonstrate the integrated implementation of various ultrasound-based imaging 
modules, our CLUE imaging sequence includes ultrafast US imaging, PA imaging, and 
SWEI. The combination of the first two are to detect the PFHnDs, which can be used for 
contrast-enhanced or super-resolution imaging [55-57]. The PFHnDs vaporize and 
recondense in response to pulsed-laser irradiation and their transient response requires 
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high-frame-rate US imaging [57]. In addition, the vaporization event also provides strong 
PA signals. Thus, in the CLUE imaging sequence shown in Figure 43, we used two 
respective UF imaging modules before and after laser pulses to capture the dynamic 
response of the PFHnDs (blue rectangle). The differential US (ΔUS) image, which is 
obtained by subtracting pre- and post-laser US images, is used to visualize the vaporized 
PFHnDs. In addition, three SWEI sequences with three ARFs applied at different lateral 
positions (left/right/middle) follow (red rectangle). The propagation of shear waves was 
visualized through a two-dimensional auto-correlation approach [161] and these shear 
waves were used to reconstruct the corresponding SWV maps using a two-dimensional 
cross-correlation approach [76]. Overall, IQ data generated from all imaging modules were 
saved immediately after acquisition, and the result images were processed offline. 
 
Figure 43 – A proposed CLUE imaging sequence including 5 sets of pre-laser US, PA, 
and post-laser US imaging as a function of optical fluence and three sets of SWEI 
sequences. 
 This study used a linear array ultrasound transducer (CL15-7; Philips Healthcare, 
Andover, MA, USA). Table 10 lists all parameters used in the CLUE imaging sequence. 
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Laser pulsing was repeatedly disabled and enabled to obtain pre-laser US images 
immediately prior to the actual laser pulse (for example, UF 1 is placed before ExtLaser 2 
in Figure 43). Thus, the Idle module was used to control the acquisition time. The desired 
duration of the Idle module was computed by subtracting a Q-Switch delay and a pre-laser 
US acquisition duration from the laser PRI (100 ms). Immediately after irradiating a laser 
pulse, PA imaging and subsequent post-laser US imaging followed. This study applied 5 
actual laser pulses as a function of Q-Switch delay to demonstrate its ability to adjust the 
optical fluence with respect to laser pulse, which allows for evaluation of the optical 
vaporization threshold of the PFHnDs. The Q-Switch delay decreased with each successive 
laser pulse (400, 350, 300, 270, 250 µs), increasing the irradiated optical fluence 
accordingly. The average measured fluence values were 33, 54, 77, 90, and 94 mJ/cm2. 
 SWEI in the CLUE imaging sequence consisted of three ARF applications and 
three ultrafast ultrasound acquisitions to obtain the mechanical properties of tissue. As 
listed in Table 10, the ARFs were applied at three lateral locations and the propagation of 
the shear waves were respectively tracked at a PRF of 10 kHz. Three angles of plane waves 
were used for angular compounding [73]. For the ARF beams, f-number of 2.5, a focal 
depth of 17.5 mm, a pulse duration of 200 µs, and a center frequency of 6.5 MHz were 
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7.3.2 Synthesis of Perfluorohexane Nanodroplets (PFHnDs) 
 Perfluorohexane nanodroplets were synthesized using a sonication-based protocol. 
Briefly, 1 µmol of DSPC and DSPE-mPEG2000 in a 1:9 molar ratio were isolated along 
with 0.5 mg of near-infrared-absorbing dye (IR-1048; Sigma-Aldrich) from a chloroform 
solution using a rotary evaporator. After rotary evaporation produced an even cake of lipid 
and dye, the solid isolate was further dried under nitrogen flow in order to evaporator all 
residual chloroform. 
 Next, the solid reagents were hydrated with 1 mL of 7.40 pH PBS and agitated 
using a water bath sonicator to produce a solution of dye-loaded nanomicelles. This 
solution was centrifuged at 300 rcf for 1 minute in order to pellet excess near-infrared dye. 
Then, 900 µL of the nanomicelle-containing supernatant was combined with 100 µL of 
PBS and 50 µL of perfluorohexane. This solution was then probe sonicated (1s on, 15 s 
off, 5 times) on ice in order to produce a stock solution of PFHnDs. 
 Prior to their use for imaging, 100 µL of PFHnDs were diluted in 2 mL of PBS and 
bath sonicated for 5 minutes. This solution would then be centrifuged at 3000 rcf for 5 
minutes in order to pellet PFHnDs. The supernatant would then be removed and the 
PFHnDs would be reconstituted in 100 µL of sterile saline for imaging. This protocol 
produces PFHnDs with an average hydrodynamic diameter of 222 nm measured via 
dynamic light scattering (Zetasizer Nano ZS; Malvern Instruments Ltd.) and at a 
concentration of approximately 1010 PFHnDs/mL as assessed by nanoparticle tracking 
analysis (NanoSight NS300; Malvern Panalytical). 
7.3.3 Tissue-Mimicking Phantom Synthesis and Imaging 
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 A tissue-mimicking gelatin phantom containing a cylindrical stiff inclusion labeled 
with the synthesized PFHnDs was fabricated to demonstrate the CLUE imaging sequence. 
The diameter of the inclusion was 7 mm. The concentrations of the gelatin powders in the 
inclusion and background were 12% w/v and 6% w/v, respectively. Thus, a SWV ratio of 
the inclusion to the background was expected to be two, as the stiffness of a gelatin 
phantom is proportional to its gelatin concentration. The v/v ratio of the as-prepared 
PFHnDs solution to the inclusion was 1:1000. For acoustic scattering, 0.5% w/v silica 
particles were included both in the inclusion and in the background. The imaging depth of 
the center of the inclusion was approximately 17.5 mm. The CLUE imaging sequence was 
repeated three times to evaluate means and standard deviations (SDs) of the pre-laser US, 
PA, post-laser US, ΔUS, and SWV images over independent measurement. 
7.3.4 Mouse Spleen Preparation for Ex Vivo Imaging 
 All animal procedures were performed under the oversight of the Institutional 
Animal Care and Use Committee at the Georgia Institute of Technology. For ex vivo spleen 
imaging, an 18-week-old female athymic nude mouse (NU/J; The Jackson Laboratory) was 
placed under general anesthesia with isoflurane (5% induction, 2.5% maintenance; 0.5 
L/min O2) and injected via the jugular vein with 140 µL of 10
10 PFHnD/mL particles, 
prepared as described in section “B.” After injection, the mouse was returned to 
consciousness and kept in the Animal Resources Facility at Georgia Tech for 24 hours. 
This time allows for injected particles to be filtered within splenic sinusoids and 
endocytosed by resident reticuloendothelial cells. After 24 hours, the mouse was humanely 
euthanized by an intraperitoneal lethal injection of Euthasol (Sodium pentobarbital 390 
mg/ml, 150 mg/kg; Henry Schein Medical). Following cessation of the heartbeat, 
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euthanasia was confirmed by secondary cervical dislocation. Immediately after secondary 
euthanasia, the spleen was dissected and kept submerged in 6.80 pH-buffered PBS solution 
prior to phantom inclusion. 
 Within two hours post-resection, the mouse spleen was immediately embedded in 
a gelatin phantom to fix its movement and improve the acoustic coupling. Then, the mouse 
spleen was imaged using the same CLUE imaging sequence as described previously. 
7.4 Results and Discussion 
7.4.1 CLUE Imaging of a Phantom Containing a Stiff Inclusion 
 
Figure 44 – Processed pre-laser US, PA, post-laser US, and ΔUS images as a function 
of optical fluence obtained from the tissue-mimicking gelatin phantom. 
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 The CLUE imaging sequence introduced in Figure 43 was applied to the gelatin 
phantom containing a stiff cylindrical inclusion. Figure 44 shows the corresponding pre-
laser US, PA, post-laser US, and ΔUS images as a function of laser pulse. At the lowest 
fluence (i.e., 33 mJ/cm2) in Figure 44 (a) and (p), almost no PA and ΔUS signals were 
detectable, and thus, we conclude that the laser pulse at this fluence level did not activate 
the PFHnDs. As optical fluence increased from 33 mJ/cm2 to 94 mJ/cm2, the number of 
triggered PFHnDs increased, resulting in the growing PA and ΔUS signals. However, in 
pre- and post-laser B-scan US images (the first and third row images), no obvious 
differences were observable. This is because the signals coming from the vaporized 
PFHnDs were relatively subtle compared to those from other acoustic scatters in the 
phantom. Thus, taking a difference between pre- and post-laser US images (i.e., ΔUS 
images) shown in the fourth row (Figure 44 (p), (q), (r), (s), and (t)) could be useful in 
identifying the optical activation of the PFHnDs for high-contrast imaging. 
 
Figure 45 – Means and SDs of PA signals obtained inside and outside of the inclusion 
as a function of optical fluence. 
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 Means and SDs of the PA signals in the stiff inclusion (region-of-interest for the 
inclusion is circled with a white dotted line in Figure 44 (a)) and in the background region 
were computed with three measurements as shown in Figure 45. The background mean PA 
signals did not change significantly with respect to optical fluence and were consistently 
negligible (gray dotted line), but the PFHnDs contained in the inclusion resulted in 
increasing mean PA signals (black solid line). As the vaporization process is a combined, 
complex function of various factors including droplet size, local fluence, amount of dye 
encapsulated, and local temperature [57], the PFHnDs vaporize stochastically. Thus, the 
vaporization threshold is unique to each formulation. Therefore, the increase in the mean 
PA signal resulting from the expansion of the PFHnDs is not completely discrete as shown 
in Figure 45. 
 
Figure 46 – Combined 5 sets of means of pre- and post-laser US signals in the inclusion 
as a function of US frame. 
 Mean ultrasound signals of all 5 sets from both pre- and post-laser US images are 
shown together as a time series in Figure 46 as a function of frame. Since we acquired two 
pre-laser US frames and 20 post-laser US frames per laser pulse, the application of five 
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laser pulses produced a total of 110 (5 x 22) US frames. Every first two frames in 22 frames 
are pre-laser US frames indicated with black circles and the other 20 frames are post-laser 
US images indicated with blue x marks. The first three sets did not obviously show clear 
changes between pre- and post-laser US signals. The fourth and fifth transitions from pre- 
to post-laser US signals are clearer, although their differences are still not substantial. 
These results indicate that when the PFHnD signals are mixed with the endogenous US 
signals from acoustic scatters, the PFHnD vaporization may not be easily detectable with 
typical grayscale US images. Pre- and post-laser US images (first and third row images in 
Figure 44) are also almost visually identical. 
  
Figure 47 – Means and SDs of ΔUS signals obtained inside and outside of the inclusion 
as a function of optical fluence. 
 ΔUS images removing background signals showed the vaporized PFHnDs with 
high contrast (fourth row images in Figure 44). Means and SDs of ΔUS signals inside and 
outside of the inclusion were computed and plotted in Figure 47. Like the results observed 
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in Figure 45, the mean ΔUS signals in the background (gray dotted line) do not change as 
a function of fluence, but those in the inclusion (black solid line) increased as optical 
fluence increased, which vaporized more PFHnDs. 
 On the same target, and at the same time, the CLUE imaging sequence obtained the 
SWEI results as shown in Figure 48. We applied three ARF beams at different lateral 
locations (−7 mm, +7 mm, and 0 mm) and observed the corresponding generation and 
propagation of the shear waves. Three rows in Figure 48 represent three lateral locations 
of ARF application. As the shear waves propagate through the stiff region, they became 
faster, as observed in the axial velocity sequences at multiple downstream time points (the 
second to fifth column images in Figure 48). The respective SWV maps reconstructed from 
each axial velocity sequence are shown in Figure 48 (f), (l), and (r). On the regions where 
the push beams were applied, the propagation of the shear waves is not observable. 
Therefore, the SWVs on the pushing regions are unreliable. This limitation typically 
requires multiple applications of ARF beams at different lateral locations to span the full 
field-of-view while still omitting unwanted regions in the SWV map prior to combining 
multiple SWV maps. 
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Figure 48 – Estimated axial velocity sequences visualizing the propagation of the 
shear waves generated at three lateral locations in the gelatin phantom and three 
corresponding SWV maps. 
 
Figure 49 – A combined SWV map overlaid on a B-scan US image of the gelatin 
phantom. 
 The combined SWV map from the three acquired SWV maps is given in Figure 49. 
The inclusion center was placed at 17.5 mm in depth. We found that mean SWVs inside 
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and outside of the inclusion were 4.22 m/s, and 2.81 m/s, respectively. The ratio of square 
of them was 2.27, which is close to the ratio of the gelatin concentration of the inclusion to 
that of the background (i.e., 12% / 6% = 2). 
 Overall, we have demonstrated that the CLUE imaging sequence is able to sense 
multiple properties of the imaging target simultaneously through our gelatin phantom 
study. The stiff PFHnD-labeled inclusion offered both the laser-induced contrast by PA 
and ΔUS imaging and mechanical contrast by SWEI. A further imaging study on a phantom 
containing multiple contrast sources distributed amongst multiple targets is necessary. 
7.4.2 CLUE imaging of Ex Vivo Spleen 
 To further demonstrate the feasibility of CLUE imaging, we imaged a cross-section 
of an ex vivo mouse spleen embedded in a homogeneous gelatin background as shown in 
Figure 50. 
 
Figure 50 – Estimated axial velocity sequences visualizing the propagation of the 
shear waves generated at three lateral locations in the phantom embedding the ex vivo 
mouse spleen and three corresponding SWV maps. 
 123 
 Similar to the gelatin inclusion study introduced in the previous section, no overt 
differences between pre- and post-laser US images can be observed over increasing optical 
fluences. However, we could confirm that the intravenously injected PFHnDs successfully 
accumulated in the spleen before extraction. Therefore, similar to the phantom case, the 
PA and ΔUS signals inside the spleen increased due to the increased vaporization of 
PFHnDs as a function of optical fluence. 
 
Figure 51 – A combined SWV map overlaid on a B-scan US image of the ex vivo mouse 
spleen. 
 From the estimated axial velocity sequences in Figure 50, it is observed that shear 
waves were successfully created and propagated through the spleen. As shown in Figure 
50, the spleen seemed to be stiffer than the gelatin background, which resulted in faster 
SWVs propagating through the spleen. Three SWV maps acquired at three lateral positions 
were again reconstructed from the corresponding axial velocity sequences, but there is a 
noticeable difference in the SWVs in the spleen between Figure 50 (f) and (l). This is 
possibly due to the unexpected broadening of shear waves [162], as the shear wave front 
in Figure 50 (e) seems to be wider (i.e., more blurred) and unclear than that in Fig. 13 (k). 
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A final SWV map of the mouse spleen combined from three SWV maps is presented in 
Figure 51. 
7.4.3 Potential Limitations and Utilities of CLUE Imaging 
 CLUE imaging may not be able to always capture all mechanical, optical, acoustic 
information in soft tissue. One of the most critical concerns would be a limitation in light 
penetration. Because of optical absorption and scattering, pulsed-laser light becomes 
diffuse in biological tissue. Although near-infrared light can reach depths at several 
centimeters, PA imaging of deep tissue is still challenging [163]. Furthermore, sPA 
imaging of chromophore concentrations gets significantly inaccurate as the imaging target 
goes deeper or the PA signal-to-noise ratio gets lower [164]. On the other hand, SWEI 
relies on the ARF application to generate and thus to monitor shear waves. However, 
because of the attenuation of shear waves, adequate generation of shear waves is desired 
[24, 27, 28]. In addition, the generation of shear waves is highly dependent on the regional 
characteristics of tissue, such as, coupling stress resulting from internal organs, boundary 
conditions, and viscoelasticity [165]. Thus, given these physical challenges in PA imaging 
and SWEI, CLUE imaging could be partially functional in a region of interest dependent 
upon depth and local tissue properties. In other words, a region of interest, where PA 
imaging is insensitive, can rely on SWEI and vice versa. 
 CLUE imaging has promising potential in various clinical applications. Not only 
does CLUE imaging help to understand progress, status, and prognosis of disease, but also 
it can be a valuable tool for therapeutic guidance. Currently, assessment of a treatment 
response of cancer is likely delayed, as monitoring the reduction of the tumor size is used 
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as a standard method [29]. Thus, it may be beneficial to apply CLUE imaging to monitor 
the changes in both mechanical and functional properties of cancer in response to specific 
therapy, as it can provide immediate and collective information on treatment progress. For 
example, sPA imaging and SWEI have shown their respective capabilities in evaluating 
various therapeutic approaches, which may be further improved with CLUE imaging [29, 
30, 40, 157]. Monitoring oxygenation of a tumor for effective therapeutic radiation 
sensitization and promptly evaluating its response to radiation would be feasible using sPA 
imaging and SWEI, respectively, which would be simultaneously possible through CLUE 
imaging. 
7.5 Conclusion 
 This chapter has introduced and designed the CLUE imaging platform and 
sequence as a research tool for comprehensive cancer diagnosis. Furthermore, the 
development of the CLUE imaging platform will also support imaging studies for 
ultrasound researchers in a wide array of disease applications. In our module-configurable, 
scalable CLUE platform, an arbitrary imaging sequence can be created by allocating pre-
defined imaging modules. To demonstrate the developed CLUE imaging platform in the 
tissue-mimicking gelatin phantom and the ex vivo mouse spleen, we have applied a 
representative CLUE imaging sequence, which can acquire pre-laser US, PA, post-laser 
US, and SWV images. The imaging results collectively showed multiple desired imaging 
contrast—acoustic, optical, and mechanical—from both the PFHnD-labeled stiff inclusion 
and the PFHnD-laden spleen, suggesting that the introduced CLUE imaging platform and 
sequence can be potentially used to provide comprehensive soft tissue assessment.  
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CHAPTER 8. CONCLUSIONS AND FUTURE WORK 
8.1 Conclusions 
Medical ultrasound imaging is one of most widely used modalities in clinic as it is 
highly portable, real-time, noninvasive, and cost-effective. However, traditional gray scale 
ultrasound imaging lacks functional, molecular, and mechanical information on tissue, 
limiting its utility as a first-line screening tool. In other words, because comprehensive 
diagnostic information on cancer and other diseases is unattainable with ultrasound 
imaging, accurate and early diagnosis is challenging in ultrasound imaging. 
To alleviate this limitation and improve the utility of ultrasound imaging, various 
ultrasound-based imaging techniques including SWEI, sPA imaging, and imaging of 
PFHnDs have been investigated. The primary goals of this research are to engineer and 
improve these imaging methods to enhance their diagnostic abilities, and ultimately, to 
combine these imaging techniques in a configurable CLUE imaging platform to enable 
comprehensive diagnosis of cancer with single imaging modality. 
Due to the previous studies from researchers in this field and fruitful collaboration 
with lab members, this research could advance these imaging techniques. For SWEI, the 
effective use of multi-angular shear waves utilizing grating lobes was proposed and 
verified that it can improve the quality of shear-wave velocity images. For sPA imaging, a 
depth-optimized wavelength selection method was introduced and demonstrated 
numerically. It was shown that the proposed method can quantify concentrations of 
chromophores accurately for improved blood oxygen saturation estimation. A method 
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localizing PFHnDs in real-time was introduced to provide sustained contrast-enhanced 
images to identify lymph node better. In addition, a temporal averaging approach that 
improves spatial resolution of super-resolution imaging with the PFHnDs was suggested 
and demonstrated. Furthermore, to utilize the full potential of the PFHnDs, multi-
wavelength PA and plane-wave US imaging was introduced and showed that it enables 
acoustic observation of the PFHnDs as a function of both optical wavelength and time. 
Lastly, an imaging platform that is able to combine all these imaging methods referred to 
as CLUE imaging platform was introduced and designed. The proposed CLUE imaging 
platform not only supports the CLUE imaging sequence itself, but also enables various 
user-specific arbitrary imaging sequences because the CLUE imaging platform is designed 
to be module-configurable and scalable. 
These technical contributions and improvements in noninvasive ultrasound imaging 
in this research will help improving comprehensive understanding of cancer and other 
diseases at an earlier stage with higher accuracy. I hope that the CLUE imaging platform 
and sequence will be used to solve various health problems, and thus, will contribute 
advances in healthcare and make our society well-being. 
8.2 Future Directions 
8.2.1 In vivo Human Thyroid Study using Multiangular Compound Shear-Wave 
Elasticity Imaging (MAC-SWEI) 
About 95% of thyroid nodules are benign, but most patients undergo additional 
imaging studies or biopsy because their benignity cannot be accurately characterized by 
standard ultrasound scanning [166, 167]. Thus, as one of on-going studies in our laboratory, 
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MAC-SWEI has been applied to human patients with thyroid nodules to assess its ability 
in differentiating malignant from benign thyroid nodules. When using the MAC-SWEI, 
three pushing configurations created with Δϕ’s of 0°, 140°, and 180° have been applied in 
the middle of the transducer and two pushing configurations with Δϕ of 0° have been 
applied sequentially in the left and the right sides of the transducer [28]. Thus, five pushing 
and tracking sequences have been applied to each patient and resulted in four shear wave 
velocity (SWV) images—one from the first three pushing and the other from the last two 
pushing—through off-line post-processing. The specificity and the sensitivity of each 
SWV image with the corresponding pathology results will be evaluated. The Emory 
institutional review board (IRB) had approved our system and imaging protocol, and 
patient scanning has been started from November 2017. The total number of patients 
scanned is to be more than 20 patients. 
8.2.2 Combined Laser, Ultrasound, and Elasticity (CLUE) Imaging for In Vivo Mouse 
Breast Cancer Characterization 
The developed and demonstrated CLUE imaging platform and sequence will be 
further evaluated with preclinical mouse model of breast cancer. Not only diagnosis of 
cancer, but also monitoring therapeutic response of cancer will be investigated. To evaluate 
malignancy of a tumor and detect the cancer early, rigorous studies on SWEI, sPA imaging, 
and contrast-enhanced US imaging have been investigated in this research field. However, 
these studies have been studied independently, and none of combined comprehensive 
imaging studies was approached. Primary and metastatic cancer shows different 
mechanical and functional properties as it progresses. Depending on its stage, changes in 
mechanical and functional properties of cancer can differ, which can be used to stage and 
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characterize the cancer. As the CLUE imaging platform and sequence uniquely provide 
quantitative mechanical, functional, and compositional information on cancer, it can be 
used for advanced cancer imaging. 
8.2.3 Three-Dimensional CLUE Imaging using a Two-Dimensional Matrix Array 
The CLUE imaging platform and sequence were developed on the Verasonics 
system using one-dimensional array transducers providing two-dimensional (2-D) images. 
The capability of the CLUE will be greatly improved if it adopts 2-D array transducers for 
three-dimensional (3-D) volume imaging as imaging a 2-D cross-section of cancer only 
shows part of cancer, limiting potential of the comprehensive CLUE imaging sequence. To 
expand the CLUE imaging sequence with a 2-D matrix array transducer, an effective data 
acquisition strategy is desired as 2-D matrix array transducers has typically at least four 
times more elements than 1-D array transducers. Our on-going research project uses a 
1024-element matrix array driven by the 256-channel Verasonics system using PCIe-based 
RF data transfer. Data transfer rate and channel memory in the Verasonics system are 
limited, and thus considered carefully. In addition, different clinical applications require 
different volume rates. Therefore, data acquisition strategy should be deliberately studied 
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